olmesartan has been researched along with Blood Pressure, High in 331 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 64 (19.34) | 29.6817 |
| 2010's | 247 (74.62) | 24.3611 |
| 2020's | 20 (6.04) | 2.80 |
| Authors | Studies |
|---|---|
| Gotou, H; Kario, K; Rakugi, H; Sasajima, T; Yamaguchi, M; Zhang, J | 1 |
| Burnier, M; Redon, J; Volpe, M | 1 |
| Abe, T; Bekki, M; Fukumoto, Y; Honda, A; Igata, S; Kurata, S; Maeda-Ogata, S; Matsui, T; Nishino, Y; Sugiyama, Y; Tahara, A; Tahara, N; Yamagishi, SI | 1 |
| Almarjan, AI; Almarjan, SA; Masoud, AT | 1 |
| Eguchi, S; Iekushi, K; Kario, K; Morita, Y; Rakugi, H; Yarimizu, D | 1 |
| Chung, SH; Joo, HJ; Kim, EJ; Kim, JH; Kim, YH; Yum, Y | 1 |
| Hong, JH; Hyun, D; Kim, GH; Kim, HL; Kim, W; Lim, S; Min, KW; Oh, J; Park, SD; Shin, J | 1 |
| Kogachi, S; Sundaram, V; Treyzon, L; Waters, K | 1 |
| Abbruzzi, F; Carparelli, S; Di Leo, A; Ierardi, E; Loconte, I; Principi, M | 1 |
| Okamura, K; Shirai, K; Takamiya, Y; Urata, H; Yano, Y | 1 |
| Cook, DR | 1 |
| Farsi, M; Gray, T; Miller, R; Ross, R; Segars, K | 1 |
| Bazylevych, AY; Bochar, OM; Bochar, VT; Faynyk, AF; Kuzminov, YB; Sklyarova, HY | 1 |
| Humbert, X; Le Bas, F; Rabiaza, A; Raginel, T; Schonbrodt, L | 1 |
| Gabb, GM; Moore, K; Shukla, N | 1 |
| Chockalingam, KC; Jayagopal, PB; Khan, MY; Mane, A; Mehta, S; Oomman, A; Pandit, S; Ramakrishnan, A; Shah, S | 1 |
| Adachi, O; Akiyama, M; Kumagai, K; Motoyoshi, N; Saiki, Y; Sasaki, K; Sato, M; Sugawara, Y | 1 |
| Arrabito, E; Battistoni, A; Filippini, A; Madaro, L; Nicoletti, C; Parente, R; Savoia, C; Steckelings, UM; Touyz, RM; Volpe, M | 1 |
| García-Buey, L; Rubín de Célix, C; Serrano, R | 1 |
| Ahn, KT; Cho, BR; Kim, BJ; Kim, DK; Lee, SY; Lee, WS; Park, JI; Sung, J | 1 |
| Del Sordo, R; Engel, PJH; Riccardi, L; Villanacci, V | 1 |
| Lauder, L; Mahfoud, F; Meyer, MR; Vollmer, AC; Wagmann, L | 1 |
| Buendia, R; Zambrano, M | 1 |
| Adachi, S; Fujisawa, K; Hitaka, Y; Ideishi, M; Inoue, A; Inoue, K; Kusumoto, T; Kuwano, T; Miura, SI; Motozato, K; Norimatsu, K; Saku, K; Shiga, Y; Shirotani, T; Yano, M | 1 |
| Bhosale, V; Hanif, K; Jagavelu, K; Jain, M; Pal, N; Singh, H; Tripathi, D | 1 |
| Battistoni, A; Coluccia, R; Mastromarino, V; Santolamazza, C; Tocci, G; Volpe, M | 2 |
| Costa, FV | 1 |
| Douros, A; Kreutz, R; Scholze, J | 1 |
| Scullin, E | 1 |
| Srinivas, NR | 1 |
| Grimm, D; Krüger, M; Nielsen, PM; Simonsen, U; Wehland, M | 1 |
| Hafeez, K; Rakugi, H; Supasyndh, O; Wang, J; Zhang, J; Zhang, Y | 1 |
| Chatzikyrkou, C; Haller, H; Izzo, J; Menne, J; Mertens, PR; Rabelink, T; Ruilope, LM; Rump, C; Viberti, G | 1 |
| Bakris, G; Kario, K; Omboni, S; Parati, G | 1 |
| Ruilope, LM; Ruiz-Hurtado, G | 1 |
| Bakris, G; Deedwania, P; Reimitz, PE; Weber, M | 1 |
| Busby, J; Cardwell, CR; Hughes, C; Johnston, BT; McMenamin, Ú; Spence, A | 1 |
| Bakris, GL; Cushman, WC; Kupfer, S; Lloyd, E; Roberts, A; Sica, D; Weber, MA; White, WB | 2 |
| Aizenberg, D; Chen, CW; Cheung, DG; Gorbunov, V; Hafeez, K; Zhang, J | 1 |
| van der Merwe, WM | 1 |
| Hsieh, YS; Kang, P; Kwon, S; Seol, GH; Shin, YK | 1 |
| Armario, P; Banegas, JR; de la Cruz, JJ; de la Sierra, A; Gorostidi, M; Oliveras, A; Ruilope, LM; Segura, J; Vinyoles, E | 1 |
| Kario, K; Kushiro, T; Mori, Y; Okuda, Y; Saito, I; Shimada, K; Teramukai, S; Yaginuma, M; Zenimura, N | 1 |
| Hirooka, Y; Nishihara, M; Takesue, K | 1 |
| Dufay, A; Gallo, A; Girerd, X; Hanon, O; Vaïsse, B | 1 |
| Cartee, AK; Oxentenko, AS; Reyes Genere, JP | 1 |
| Bakris, GL; Cushman, WC; Ferdinand, KC; Lloyd, E; Weber, MA; White, WB; Wu, J | 1 |
| Badri, T; Charfi, O; El Aidli, S; Kastalli, S; Lakhoua, G; Zaïem, A | 1 |
| Omboni, S; Volpe, M | 2 |
| Shenbagaraj, L; Swift, G | 1 |
| Elisaf, MS; Florentin, M; Liamis, G; Makri, A | 1 |
| Carvalho-Tavares, J; Castro-Faria Neto, H; Estato, V; Freitas, FS; Lessa, MA; Obadia, N; Reis, P; Tibiriçá, E | 1 |
| Dohi, Y; Hirota, H; Isaka, N; Ito, M; Kato, T; Kimura, G; Kojima, M; Machida, H; Makino, K; Miyagawa, K; Mizubayashi, R; Mizuno, O; Nakatani, K; Okamoto, S; Okubo, S; Okura, T; Takeuchi, M | 1 |
| Araki, N; Ishigami, T; Kakizoe, Y; Kitamura, K; Maeda, E; Minegishi, S; Tamura, K; Umemura, M; Umemura, S; Ushio-Yamana, H | 1 |
| Amano, T; Harada, K; Ichimiya, S; Ishii, H; Kanashiro, M; Kobayashi, M; Kurebayashi, N; Marui, N; Murohara, T; Sone, T; Suzuki, S; Tsuboi, H; Uetani, T; Yoshikawa, D | 1 |
| Hou, CJ; Hsia, CH; Lai, WT; Lin, TH; Pan, JP; Tsai, CD; Tsai, JP | 1 |
| Di Renzo, G; Izzo, R; Manzi, MV; Marino, M; Rozza, F; Santoro, M; Trimarco, B; Trimarco, V | 1 |
| Saito, Y; Takami, T | 2 |
| Hitomi, H; Ichihara, A; Kobori, H; Kohno, M; Masaki, T; Mori, H; Morimoto, S; Murase, M; Nakano, D; Nishiyama, A; Ohmori, K; Ohnishi, K; Pelisch, N | 1 |
| Miura, M; Miyata, S; Nochioka, K; Sakata, Y; Shiba, N; Shimokawa, H; Tadaki, S; Takada, T | 1 |
| Dimitriadis, F; Kinoshita, Y; Martin, DT; Ohmasa, F; Oikawa, R; Oiwa, H; Saito, M; Satoh, I; Shimizu, S; Tomita, S; Tsounapi, P | 1 |
| Carbone, A; Cicero, AF; D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Querci, F | 5 |
| Hiramatsu, K; Ishikawa, Y; Kario, K; Kobayashi, F; Kushiro, T; Saito, I; Shimada, K; Teramukai, S | 1 |
| Hiramatsu, K; Kario, K; Kobayashi, F; Kushiro, T; Mori, Y; Saito, I; Shimada, K; Teramukai, S | 1 |
| Chan, JC; Haneda, M; Harada, A; Imai, E; Ito, S; Kobayashi, F; Makino, H; Yamasaki, T | 1 |
| Bramlage, P; Fronk, EM; Ketelhut, R; Schmieder, RE; Wolf, WP; Zemmrich, C | 1 |
| Chrysant, SG | 1 |
| Allen, RR; Ghushchyan, V; Kaila, S; Nair, KV; Saseen, JJ | 1 |
| Bramlage, P; Fimmers, R; Gansz, A; Lüders, S; Nadal, J; Schmieder, RE; Schrader, J; Sturm, CD; Zemmrich, C | 2 |
| Miura, S; Saku, K | 2 |
| Tocci, G; Volpe, M | 1 |
| DiNicolantonio, JJ; Elisaf, MS; Liberopoulos, EN; Rizos, CV; Tellis, K; Tselepis, AD | 1 |
| Amaya, N; Arakawa, K; Fukuoka, Y; Ishida, K; Lee, JD; Morishita, T; Nakano, A; Tada, H; Uzui, H | 1 |
| Ruilope, L; Schaefer, A | 1 |
| Bregvadze, TR; Mishchuk, NE; Tseluĭko, VI | 1 |
| Fabrizzi, P; Malacco, E; Mallion, JM; Omboni, S; Volpe, M | 1 |
| Akbal, E; Akyürek, N; Akyürek, Ö; Güneş, F | 1 |
| Brunel, P; Cardenas, P; Cockcroft, JR; Hester, A; Kario, K; Williams, B; Zappe, DH; Zhang, J | 1 |
| Caffrey, JL; Chang, CH; Lai, MS; Lin, JW; Wu, LC | 1 |
| de la Sierra, A; Kreutz, R; Laurent, S; Manolis, AJ; Volpe, M | 1 |
| Etminan, M; Eurich, DT; Lin, M; Padwal, R | 1 |
| Arakawa, K; Jinnouchi, H; Jinnouchi, T; Kim-Mitsuyama, S; Matsui, K; Ogawa, H | 3 |
| Daikuhara, H; Fukunaga, K; Ohshima, T | 1 |
| Cui, X; Fu, M; Ge, J; Hu, K; Liao, J; Sun, A; Xu, J; Zhou, J; Zhu, H; Zou, Y | 1 |
| Halleck, F; Holleck-Weithmann, S; Kossmehl, P; Kreutz, R; Rothermund, L; Schröder, K | 1 |
| Bramlage, P; Fronk, EM; Ketelhut, R; Schmieder, RE; Smolnik, R; Wolf, WP; Zemmrich, C | 1 |
| Ammentorp, B; de la Sierra, A; Laeis, P; Volpe, M | 1 |
| Cheng, XW; Dai, Q; Hao, C; Murohara, T; Wu, H; Yao, H; Zhang, Z | 1 |
| Janssen, J; Mulder, CJ; Nijeboer, P; van Beurden, YH; Verbeek, WH | 1 |
| Ateş, AH; Aytemir, K; Canpolat, U; Güven, GS; Karahan, S; Kaya, B; Sendur, MA; Sunman, H; Yorgun, H | 1 |
| Akasaka, H; Furuhashi, M; Fuseya, T; Ishimura, S; Mita, T; Miura, T; Moniwa, N; Ohnishi, H; Ohno, K; Saitoh, S; Shibata, S; Shimamoto, K; Takizawa, H; Tanaka, M; Ura, N; Watanabe, Y; Yoshida, H | 1 |
| Kirchner, F; Kreutz, R; Limberg, R; Scholze, J; Weinstock, A | 1 |
| Llobell, A; Milisenda, JC; Pellicé, M; Téllez, A | 1 |
| Bilo, G; Hoshide, S; Koch, W; Parati, G | 1 |
| Agudo Fernández, S | 1 |
| Hayashi, K; Higaki, J; Horiuchi, M; Imaizumi, T; Ishimitsu, T; Ito, S; Kashihara, N; Katayama, S; Kimura, G; Matsuoka, H; Morita, S; Odawara, M; Ogihara, T; Rakugi, H; Saito, I; Saruta, T; Shimada, K; Shimamoto, K; Takishita, S; Tanahashi, N; Teramukai, S; Umemura, S; Ura, N | 1 |
| Boutouyrie, P; Laurent, S | 1 |
| Hasegawa, Y; Katayama, T; Kim-Mitsuyama, S; Koibuchi, N; Ma, M; Maeda, M; Nakagawa, T; Ogawa, H; Sueta, D; Toyama, K; Uekawa, K; Waki, H | 1 |
| O'Brien, E | 1 |
| Izumikawa, Y; Kato, H; Kojima, K; Kubo, E; Nagura, M; Nosaka, H; Shima, T; Shimada, M; Shiraishi, T; Tanemoto, M; Tomioka, S; Uchida, S; Ueda, S; Yano, H | 1 |
| Kawamori, R; Miyazaki, S; Okuda, Y; Sato, Y; Shirayama, M; Teramoto, T; Teramukai, S | 1 |
| Cano Ruiz, A; Crespo Pérez, L; Moreira Vicente, V; Téllez Villajos, L | 1 |
| Imanishi, M; Kitabayashi, C; Kobori, H; Kohno, M; Konishi, Y; Masaki, T; Mori, H; Morikawa, T; Nishiyama, A; Rafiq, K | 1 |
| Ammentorp, B; de la Sierra, A; Kreutz, R; Laeis, P | 1 |
| Higaki, J; Ito, S; Matsuoka, H; Ogihara, T; Rakugi, H; Saito, I; Saruta, T; Shimada, K; Shimamoto, K; Teramukai, S | 2 |
| Chin, HJ; Choi, BS; Hwang, JH; Kim, DK; Kim, S; Lee, SH; Lim, CS; Park, JH; Shin, SJ | 1 |
| Aoki, M; Kawahata, H; Moriguchi, A; Morishita, R; Nakagami, H; Ogihara, T; Sotobayashi, D; Yu, H | 1 |
| di Mario, C; Francis, DP; Hayward, C; Krum, H; Lyon, AR; Ozdemir, BA; Patel, HC; Rosen, SD | 1 |
| Barvaliya, MJ; Naik, VN; Shah, AC; Tripathi, CR | 1 |
| Angeloni, E; Lombardo, P; Pirelli, M; Refice, S; Vitaterna, A | 1 |
| Anderson, AS; Boutagy, NE; Davy, BM; Davy, KP; Frisard, MI; Hulver, MW; Marinik, EL; McMillan, RP; Rivero, JM | 1 |
| Bramlage, P; Fronk, EM; Schmieder, RE; Smolnik, R; Sutton, G; Wolf, WP | 1 |
| Fukuchi, M; Goto, T; Hiramoto, T; Ibayashi, S; Inoue, K; Ishide, N; Kato, A; Komaru, T; Maruyama, Y; Miura, M; Miyata, S; Nakagawa, M; Nochioka, K; Nozaki, E; Ohe, M; Saga, C; Sakata, Y; Sekiguchi, N; Shiba, N; Shimokawa, H; Shinozaki, T; Sugi, M; Takada, T; Takahashi, J; Tamaki, K; Tsuji, I | 2 |
| Matrosova, IB; Mel'nikova, EA; Oleĭnikov, VÉ | 1 |
| Ando, H; Fujimura, A; Harada, K; Ioka, T; Ishikawa, S; Nakashima, H; Shiga, T; Ushijima, K | 1 |
| Schlimpert, V | 1 |
| Hung, CS; Li-Ching, H; Miin-Jye, W; Shing, KK | 1 |
| Ding, Z; Ge, J; Gong, H; Jiang, G; Li, Y; Wang, S; Wang, X; Wu, J; Ye, Y; Yin, P; Yuan, J; Zhang, W; Zhou, J; Zou, Y | 1 |
| Ahn, Y; Bae, JH; Jung, HW; Kang, DH; Kim, CH; Kim, KI; Park, CG | 1 |
| Brazier, JE; Guest, JF; Haag, U; Marques da Silva, P; Soro, M | 1 |
| Etoh, T; Kita, T; Kitamura, K; Nakada, S; Ohya, Y; Sakima, A; Shimokubo, T; Takishita, S; Tamaki, N; Yokota, N | 1 |
| Higaki, J; Katayama, S; Kawai, T; Kimura, G; Odawara, M; Ogihara, T; Rakugi, H; Saito, I; Saruta, T; Shimada, K; Tanahashi, N; Teramukai, S | 1 |
| Colardelle, P; Ould Sidi Mohamed, M | 1 |
| Kushiro, T; Matsushita, Y; Okutani, Y; Sagawa, K; Saito, I; Sato, Y; Tanaka, Y; Tanigawa, M | 1 |
| Ahn, SY; Bae, E; Chin, HJ; Choi, BS; Han, SS; Kim, DK; Kim, S; Lee, SH; Lim, CS; Park, JH; Shin, SJ | 1 |
| Ishikawa, Y; Kario, K; Kobayashi, F; Kushiro, T; Saito, I; Shimada, K; Teramukai, S | 1 |
| Ruilope, LM | 2 |
| Garland, K; Rishi, A | 1 |
| Malacco, E; Mallion, JM; Omboni, S; Volpe, M | 1 |
| Kawamori, R; Miyazaki, S; Okuda, Y; Shirayama, M; Teramoto, T; Teramukai, S | 1 |
| Kario, K; Kobayashi, F; Kushiro, T; Mori, Y; Okuda, Y; Saito, I; Shimada, K; Teramukai, S; Yaginuma, M | 1 |
| Evdokimova, AG; Ryzhova, YV | 1 |
| Pichler, G; Redon, J | 2 |
| Campos Ruiz, A; Marra-López Valenciano, C; Urtasun Arlegui, L | 1 |
| Cricelli, C; Cricelli, I; Lapi, F; Levi, M; Parretti, D; Pasqua, A; Piccinni, C | 1 |
| Asayama, K; Haga, T; Hosaka, M; Imai, Y; Inoue, R; Kikuya, M; Mano, N; Metoki, H; Murakami, T; Obara, T; Ohkubo, T; Satoh, M | 1 |
| D'Angelo, A; Derosa, G; Maffioli, P; Mugellini, A; Pesce, RM | 1 |
| Arimoto, M; Hata, H; Osaka, S; Sakino, H; Sezai, A; Shiono, M; Yaoita, H | 1 |
| Ishikawa, Y; Kario, K; Kushiro, T; Okuda, Y; Saito, I; Shimada, K; Teramukai, S; Zenimura, N | 1 |
| Gialama, F; Kourlaba, G; Maniadakis, N; Tsioufis, K | 1 |
| Arcand, R; Bensoussan, M; Désilets, E; Desruisseaux, C; Manière, T; Poirier, G; Tran, HK; Wisniewski, A | 1 |
| Arnason, T; Igoe, J; Kulai, T; MacIntosh, D | 1 |
| Dolci, M; Guaraldi, G; Lonardo, A; Mascia, MT; Nascimbeni, F; Reggiani Bonetti, L; Romagnoli, D | 1 |
| Kario, K; Kushiro, T; Mori, Y; Okuda, Y; Saito, I; Shimada, K; Teramukai, S; Yaginuma, M | 1 |
| Kodati, D; Kotakonda, HK; Yellu, N | 1 |
| Cao, C; Perez, A | 1 |
| Goette, A; Güvenir, HA; Karaagaoglu, E; Katircioglu-Öztürk, D; Meinertz, T; Okutucu, S; Oto, A; Oto, E | 1 |
| Drenjancevic, I; Mihalj, M; Rucevic, S; Tadzic, R; Vcev, A | 1 |
| Hanayama, Y; Kakio, Y; Okuyama, Y; Takeuchi, H; Uchida, HA; Umebayashi, R; Wada, J | 1 |
| Fukui, M; Hasegawa, G; Matsumoto, S; Nakamura, N; Oyabu, C; Tanaka, M; Ushigome, E; Ushigome, H; Yamazaki, M; Yokota, I | 1 |
| Alibrandi, A; Aragona, CO; Basile, G; Cairo, V; D'Ascola, A; Imbalzano, E; Lo Gullo, A; Loddo, S; Mandraffino, G; Morace, C; Mormina, E; Quartuccio, S; Saitta, A; Scuruchi, M | 1 |
| Bramlage, P; Kreutz, R; Limberg, R; Schmidt, AC | 1 |
| Cheng, XW; Izawa, H; Kim, W; Kobayashi, M; Kuzuya, M; Murohara, T; Nagata, K; Nishizawa, T; Obata, K; Okumura, K; Sasaki, T; Sato, K; Shi, GP; Yamada, T; Yokota, M | 1 |
| Agabiti-Rosei, E; Assanelli, D; Boari, GE; De Ciuceis, C; Favero, G; Flati, V; Martinotti, S; Paiardi, S; Pasini, E; Platto, C; Porteri, E; Rezzani, R; Rizzoni, D; Rodella, LF; Speca, S; Toniato, E | 1 |
| Fukumoto, Y; Ito, K; Nawata, J; Onoue, N; Shimokawa, H; Sugimura, K; Tada, T; Wang, H; Zhulanqiqige, D | 1 |
| Abe, H; Adachi, H; Hattori, S; Irino, H; Kitada, H; Miyatake, K; Morisawa, D; Noda, Y; Sasaki, T; Yasuoka, Y | 1 |
| Azuma, K; Horiuchi, M; Kimura, K; Masuda, S; Matsuda, M; Mogi, M; Ozawa, M; Shigenaga, A; Tamura, K; Tsurumi-Ikeya, Y; Uchino, K; Umemura, S; Wakui, H | 1 |
| Inagaki, K; Mochly-Rosen, D; Palaniyandi, SS | 1 |
| Enjoji, M; Higuchi, N; Kato, M; Kohjima, M; Kotoh, K; Nakamuta, M; Nakashima, M | 1 |
| Oparil, S; Pimenta, E | 1 |
| Hamamoto, Y; Honjo, S; Ikeda, H; Koshiyama, H; Nabe, K; Wada, Y | 1 |
| Agabiti-Rosei, E; Laeis, P; Ludwig, M; Scholze, J; Schremmer, D; Schwandt, P; Stumpe, KO; Zielinski, T | 1 |
| Pimenta, E | 1 |
| Ayala, DE; Chayan, L; Fernandez, JR; Hermida, RC; Mojon, A | 1 |
| Ansari, A; Braun, N; Handrock, R; Klebs, S; Ulmer, HJ | 1 |
| Higaki, J; Horiuchi, M; Imaizumi, T; Ito, S; Katayama, S; Matsuoka, H; Ogihara, T; Rakugi, H; Saito, I; Saruta, T; Shimada, K; Shimamoto, K; Takishita, S | 1 |
| Kuji, T; Masuda, S; Okano, Y; Tamura, K; Tochikubo, O; Umemura, S | 1 |
| David, S; Fliser, D; Haller, H; Kielstein, JT; Kümpers, P; Lukasz, A | 1 |
| Falvey, H; Lowy, A; Müller, E; Nixon, RM | 1 |
| Arakawa, K; Jinnouchi, T; Kim-Mitsuyama, S; Matsui, K; Ogawa, H | 1 |
| de Souza Mendonça, L; Fernandes-Santos, C; Mandarim-de-Lacerda, CA | 1 |
| Dominiczak, AF; Fields, L; Graham, D; Hamilton, CA; Koh-Tan, HH; McBride, MW; Nicoll, G; Young, B | 1 |
| Kubota, N; Matsuyama, N; Nakajima, T; Suzuki, H; Takeyama, Y; Tsutsumi, T | 1 |
| Chavanu, KJ; Dubiel, R; Rosendorff, C; Xu, J | 1 |
| Futai, R; Ito, T; Kawanishi, Y; Kitaura, Y; Terasaki, F | 1 |
| Vivencio, B | 1 |
| Ikeda, H; Jin, D; Miyazaki, M; Sakonjo, H; Takai, S | 1 |
| Harada, N; Okajima, K; Shimozawa, N | 1 |
| Eguchi, K; Ishikawa, J; Kario, K; Matsui, Y; Miyashita, H; O'Rourke, MF; Shimada, K | 1 |
| García De La Villa, B; Tofé Povedano, S | 1 |
| Akabane, T; Ishimitsu, T; Masuda, T; Matsuoka, H; Minami, J; Numabe, A; Okamura, A | 1 |
| Arakawa, K; Kuramoto, K; Tanigawara, Y; Yoshihara, K | 1 |
| Kawahira, K; Matsumoto, S; Miyata, R; Shimodozono, M | 3 |
| Araki, S; Hirooka, Y; Kishi, T; Sunagawa, K; Utsumi, H; Yasukawa, K | 1 |
| David, S; Fliser, D; Haller, H; Kielstein, JT; Lorenzen, JM; Neunhöffer, H | 1 |
| Ban, N; Endo, K; Kawana, H; Miyashita, Y; Nagayama, D; Ohira, M; Oyama, T; Saiki, A; Shirai, K; Yamaguchi, T | 1 |
| Fujii, M; Horie, M; Kawahara, C; Nishiyama, K; Tsutamoto, T; Yamaji, M; Yamamoto, T | 1 |
| Masuda, S; Okano, Y; Ozawa, M; Tamura, K; Tochikubo, O; Umemura, S | 1 |
| Coto-Segura, P; García-Varona, A; Mas-Vidal, A; Santos-Juanes, J | 1 |
| Kereiakes, DJ; Neutel, JM; Shojaee, A; Stoakes, KA; Waverczak, WF; Xu, J | 1 |
| Dohi, Y; Kimura, G; Miyagawa, K; Nakazawa, A; Sato, K; Sugiura, T; Yamashita, S | 1 |
| Chrysant, SG; Heyrman, R; Karki, S; Lee, J; Melino, M | 1 |
| Corradi, L; Derosa, G; Fogari, R; Malamani, G; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Benndorf, RA; Böger, RH; Divac, N; Haefeli, WE; Herzog, M; Sauer, A; Schwedhelm, E; Weiss, J | 1 |
| Fujino, M; Imaizumi, S; Karnik, SS; Kiya, Y; Miura, S; Saku, K | 1 |
| Elisaf, MS; Florentin, M; Kostapanos, MS; Kostara, CE; Liberopoulos, EN; Milionis, HJ; Rizos, CV | 1 |
| Ikeda, K; Kawabe, K; Nagata, R | 1 |
| Barrios, V; Escobar, C | 1 |
| Cicero, AF; D'Angelo, A; Derosa, G; Ferrari, I; Fogari, E; Gravina, A; Maffioli, P; Mereu, R; Palumbo, I; Salvadeo, SA | 1 |
| Dubiel, R; Kereiakes, DJ; Maa, JF; Neutel, JM; Punzi, H; Shojaee, A; Waverczak, WF | 1 |
| Makris, T; Stefanadis, C; Thomopoulos, C; Tsioufis, C | 2 |
| Kamide, K; Maekawa, Y; Ohishi, M; Onishi, M; Rakugi, H; Takeya, Y; Tatara, Y; Yamamoto, K | 1 |
| Chen, R; Eisner, C; Hu, X; Huang, Y; Kopp, JB; Leelahavanichkul, A; Mizel, D; Schnermann, J; Star, RA; Wright, EC; Yan, Q; Yuen, PS; Zhou, H | 1 |
| Hoshino, A; Matsubara, H; Nakamura, T | 1 |
| Ferrario, CM; Smith, RD | 1 |
| Bramlage, P; Erdlenbruch, W; Fronk, EM; Ketelhut, R; Schmieder, RE; Stuhr, T; Wolf, WP | 1 |
| Akcay, A; Bavbek, N; Isik, A; Kargili, A; Kasapoglu, B; Kirbas, I | 1 |
| Bilo, G; Hoshide, S; Lonati, L; Ochoa, JE; Parati, G; Ramos, C | 1 |
| Bramlage, P; Erdlenbruch, W; Fronk, EM; Ketelhut, R; Schmieder, RE; Stuhr, T; Wasem, J; Wolf, WP | 1 |
| Alemdar, R; Aydin, M; Basar, C; Bulur, S; Caglar, O; Erden, I; Ordu, S; Ozhan, H | 1 |
| Aller, R; Castro, MJ; Conde, R; De Luis, DA; Gonzalez Sagrado, M; Izaola, O; Perez Castrillon, JL; Romero, E | 1 |
| Doi, M; Hirohata, S; Izumi, R; Kamikawa, S; Kusachi, S; Miyoshi, T; Ninomiya, Y; Ogawa, H; Sakane, K; Usui, S | 1 |
| Comi-Diaz, C; Martinez-Martin, FJ; Pedrianes-Martin, P; Peiro-Martinez, I; Rodriguez-Rosas, H; Soriano-Perera, P | 1 |
| Ayabe, T; Eto, T; Kariya, S; Kato, J; Kita, T; Kitamura, K; Tamaki, N; Yokota, N | 1 |
| Haller, H; Ito, S; Izzo, JL; Januszewicz, A; Katayama, S; Mimran, A; Rabelink, AJ; Ritz, E; Ruilope, LM; Rump, LC; Viberti, G | 1 |
| Hitomi, H; Horiuchi, M; Hosomi, N; Kobori, H; Kohno, M; Matsumoto, M; Mogi, M; Nakano, D; Nishiyama, A; Pelisch, N; Sakamoto, H; Shimada, K; Ueno, M | 1 |
| Alvarez-Martín, C; Belén Ferro-Rey, M; de Salas-Cansado, M; Roca-Cusachs, A; Sicras-Mainar, A | 1 |
| Dohi, T; Inoshita, A; Ishiwata, S; Kasagi, S; Kasai, T; Maeno, K; Momomura, S; Narui, K; Ohno, M; Takaya, H; Yamaguchi, T | 1 |
| Kreutz, R; Schaefer, A; Scholze, J | 1 |
| Bakris, GL; Cao, C; Kupfer, S; Perez, A; Roberts, A; Sica, D; Weber, M; White, WB | 1 |
| Bakris, GL; Cao, C; Kupfer, S; Perez, A; Sica, D; Weber, MA; White, WB | 1 |
| Adachi, T; Ayaori, M; Iizuka, M; Ikewaki, K; Komatsu, T; Ohsuzu, F; Sasaki, M; Takase, B; Takiguchi, S; Uto-Kondo, H | 1 |
| Kim, HJ; Rodríguez-Iturbe, B; Sato, T; Vaziri, ND | 1 |
| McInnes, GT | 1 |
| Scholze, J | 1 |
| Ando, K; Fujita, M; Fujita, T; Kawarasaki, C; Kawarazaki, H; Matsui, H; Muraoka, K; Nagae, A | 1 |
| Kreutz, R | 1 |
| Ruilope, LM; Schaefer, A | 1 |
| Ando, K; Fujita, T; Haneda, M; Ito, S; Kashihara, N; Kishimoto, J; Nangaku, M; Node, K; Shimosawa, T | 1 |
| Graff, A; Hsueh, WA; Jones, CJ; Littlejohn, TJ; Nesbitt, SD; Neutel, JM; Qian, C; Shojaee, A; Waverczak, WF; Weir, MR | 1 |
| Maa, JF; Punzi, H; Shojaee, A; Waverczak, WF | 1 |
| Abe, M; Maruyama, N; Matsumoto, K; Matsumoto, S; Okada, K; Soma, M | 1 |
| Belsey, JD | 1 |
| Hayashi, K | 1 |
| Asai, S; Nakayama, T; Nishida, Y; Soma, M; Takahashi, Y | 1 |
| Narkiewicz, K | 1 |
| Azuma, K; Dejima, T; Haku, S; Hirose, T; Kanaoka, T; Kengo, A; Kimura, K; Maeda, A; Masuda, S; Matsuda, M; Nagashima, Y; Ohsawa, M; Shigenaga, A; Tamura, K; Uchino, K; Umemura, S; Wakui, H; Yabana, M | 1 |
| Baylis, C; Moningka, NC; Sasser, JM; Tsarova, T | 1 |
| Enriquez, A; Fernandez, C; Jaramillo, JC; Mielgo, R; Vasquez, JL | 1 |
| Hata, M; Sezai, A; Shiono, M; Soma, M; Unosawa, S; Wakui, S; Yoshitake, I | 1 |
| Chan, JC; Haneda, M; Imai, E; Ito, S; Kobayashi, F; Makino, H; Yamasaki, T | 1 |
| Biskupiak, J; Qian, C; Quah, R; Ram, CV; Ramaswamy, K; Russo, PA; Ryan, A | 1 |
| Deguchi, K; Hitomi, H; Kitada, K; Kobori, H; Lei, B; Masaki, T; Minamino, T; Mori, H; Nakano, D; Nishiyama, A | 1 |
| Axthelm, C; Kaiser, E; Meister, F; Sieder, C | 1 |
| Chrysant, SG; Fernandez, V; Heyrman, R; Izzo, JL; Kereiakes, DJ; Lee, J; Littlejohn Iii, T; Melino, M; Oparil, S | 1 |
| Ageev, FT; Svirida, ON | 1 |
| Hasegawa, H; Kameda, Y; Kobayashi, Y; Komuro, I; Kubota, A; Takano, H | 1 |
| Ahbap, E; Basturk, T; Borlu, F; Damar, AB; Koc, Y; Mazi, E; Sakaci, T; Unsal, A | 1 |
| Derosa, G; Fogari, R; Maffioli, P; Mugellini, A; Perrone, T; Preti, P; Zoppi, A | 1 |
| Chrysant, SG; Fernandez, V; Heyrman, R; Izzo, JL; Kereiakes, DJ; Lee, J; Littlejohn, T; Melino, M; Oparil, S | 2 |
| Kumagai, H; Matsubara, H; Oda, T; Ohshima, N; Senda, M; Tadano, H; Takechi, H; Uchida, T; Watanabe, A; Yamamoto, K | 1 |
| Chatzykirkou, C; Haller, H; Ito, S; Izzo, JL; Januszewicz, A; Katayama, S; Menne, J; Mimran, A; Rabelink, TJ; Ritz, E; Ruilope, LM; Rump, LC; Viberti, G | 1 |
| He, WY; Lv, QZ; Wei, D | 1 |
| Hoshide, S; Ishikawa, J; Kario, K; Matsui, Y; O'Rourke, MF; Shimada, K | 1 |
| Bilo, G; Parati, G | 1 |
| Arimura, T; Miura, S; Morii, J; Sako, H; Saku, K; Shiga, Y; Sugihara, M; Uehara, Y; Zhang, B | 1 |
| Malacco, E; Mallion, JM; Omboni, S; Volpe, M; Zanchetti, A | 1 |
| Ishikawa, J; Kario, K; Matsui, Y; O'Rourke, MF; Shimada, K | 1 |
| Daikuhara, H; Ishida, T; Kikuchi, F | 1 |
| Maa, JF; Neutel, J; Shojaee, A | 1 |
| Deng, W; Jiao, Y; Ke, Y; Sun, N; Wang, J; Zhu, J | 1 |
| Araki, E; Furukawa, N; Goto, R; Ichimori, S; Ichinose, K; Iwashita, S; Kawashima, J; Maeda, T; Nishida, K; Shimoda, S; Tsuruzoe, K | 1 |
| Rich, MW | 1 |
| Adachi, H; Hoshizaki, H; Kasama, S; Kawaguchi, R; Koyama, K; Murakami, J; Oshima, S; Sato, C; Toyama, T; Yamashita, E | 1 |
| Ammentorp, B; Christian Rump, L; Laeis, P; Volpe, M | 1 |
| Hirao, K; Mikawa, T; Mori, H; Nakajima, K; Niizuma, M; Ukai, H; Umemura, S; Yamamoto, H; Yuasa, S | 1 |
| Kanematsu, Y; Kitazato, KT; Matsushita, N; Nagahiro, S; Satomi, J; Shimada, K; Sumiyoshi, M; Tada, Y; Yagi, K | 1 |
| Hiramatsu, K; Kario, K; Kobayashi, F; Kushiro, T; Saito, I; Shimada, K; Teramukai, S; Zenimura, N | 1 |
| Barkas, F; Elisaf, MS; Liamis, G; Liberopoulos, EN; Moutzouri, E; Rizos, CV | 1 |
| Azushima, K; Fujikawa, T; Kanaoka, T; Kobori, H; Maeda, A; Ohsawa, M; Tamura, K; Umemura, S; Wakui, H; Yanagi, M | 1 |
| Paneni, F; Passerini, J; Tocci, G; Volpe, M | 1 |
| Linss, G | 1 |
| Goto, SN; Mizuno, Y; Takagi, H; Umemoto, T; Yamamoto, H | 1 |
| Arao, T; Mori, H; Nishida, K; Okada, Y; Tanaka, Y | 1 |
| Buzinec, P; Ferrario, CM; Panjabi, S; Swindle, JP | 1 |
| Davy, BM; Davy, KP; Frisard, MI; Hulver, MW; Marinik, EL; Rivero, JM; Savla, JS | 1 |
| Aoyama, T; Goto, M; Goto, N; Hiei, K; Iwasa, M; Kawai, N; Kida, K; Kobayashi, H; Kojima, S; Minagawa, T; Minatoguchi, S; Oda, M; Sugishita, F; Takai, K; Tanaka, R; Watanabe, I; Yamamoto, N; Yasue, T | 1 |
| Arima, H; Iseki, K; Kohagura, K; Komiya, I; Shiohira, Y; Tokuyama, K; Toma, S; Ueda, S; Uehara, H | 1 |
| de la Sierra, A | 1 |
| de la Sierra, A; Volpe, M | 1 |
| Arakawa, N; Fujimori, I; Inoue, T; Nakamura, H; Shimakawa, E; Shimizu, Y; Toyoshi, T; Yokoyama, T; Yoshigae, Y | 1 |
| Schmieder, RE | 1 |
| Averill, DB; Brosnihan, KB; Ferrario, CM; Schiffrin, EL; Smith, RD; Yokoyama, H | 1 |
| Fujii, K; Fukuhara, M; Iida, M; Kagiyama, S; Lin, Y; Matsumura, K | 1 |
| Laeis, P; Rump, LC; Sellin, L; Stegbauer, J | 1 |
| Gao, Y; Hisaoka, M; Shiga, H; Wada, DR; Yoshihara, K | 1 |
| Pugsley, MK | 1 |
| Adachi, M; Fukui, T; Hirano, T; Kageyama, H; Okada, K; Ran, J; Saito, K | 1 |
| Byrd, LH; Charles, JA; Jotkowitz, S | 1 |
| Abe, Y; Baba, R; Fan, YY; Fujita, M; Hosomi, N; Kimura, S; Kohno, M; Miyatake, A; Nagai, Y; Nishiyama, A; Sun, GP | 1 |
| Abe, S; Ishihara, M; Ishizawa, K; Izawa, Y; Kanematsu, Y; Kawazoe, K; Motobayashi, Y; Ohnishi, H; Tamaki, T; Tsuchiya, K | 1 |
| Böhm, M; Ewald, S | 1 |
| Dong, YF; Kataoka, K; Kim-Mitsuyama, S; Lai, ZF; Matsuba, S; Ogawa, H; Tanaka, T; Tokutomi, Y; Yamamoto, E; Yamashita, T | 1 |
| Hori, M; Mano, T; Masuyama, T; Miwa, T; Nishio, M; Ohtani, T; Sakata, Y; Takeda, Y; Yamamoto, K; Yoshida, J | 1 |
| Dubiel, R; Izzo, JL; Neutel, JM; Silfani, T; Walker, F | 1 |
| Hermida, RC; Portaluppi, F; Smolensky, MH | 1 |
| Chrysant, SG; Dimas, B; Shiraz, M | 1 |
| Mitsuyama, S | 1 |
| Fujii, S; Furumoto, T; Katoh, C; Morita, K; Naya, M; Tamaki, N; Tsukamoto, T; Tsutsui, H | 1 |
| Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Fujitani, Y; Hirose, T; Ikeda, F; Kawamori, R; Mita, T; Nakayama, S; Shimizu, T; Uchino, H; Watada, H | 1 |
| Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Rinaldi, A; Zoppi, A | 1 |
| Berry, NC; Inagaki, K; Koyanagi, T; Mochly-Rosen, D; Sun, L | 1 |
| Guo, Q; Ito, O; Kanazawa, M; Kohzuki, M; Kurosawa, H; Minami, N; Mori, N; Nagasaka, M | 1 |
| Ferrario, CM; Igase, M; Kohara, K; Miki, T; Nagai, T | 1 |
36 review(s) available for olmesartan and Blood Pressure, High
| Article | Year |
|---|---|
Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Leukemia, Myeloid, Acute; Olmesartan Medoxomil | 2023 |
Different Doses of Sacubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis.
Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Blood Pressure; Drug Combinations; Essential Hypertension; Humans; Hypertension; Tetrazoles; Valsartan | 2023 |
Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Precision Medicine; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome | 2017 |
Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles; Time Factors; Treatment Outcome | 2017 |
Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cost Savings; Cost-Benefit Analysis; Drug Costs; Drug Substitution; Drug Therapy, Combination; Drugs, Generic; Humans; Hypertension; Imidazoles; Medication Adherence; Olmesartan Medoxomil; Tetrazoles; Time Factors; Treatment Outcome | 2017 |
The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure - an Update.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Heart Failure; Humans; Hypertension; Imidazoles; Natriuretic Peptides; Neprilysin; Renin-Angiotensin System; Tetrazoles; Treatment Outcome; Valsartan | 2018 |
Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Tetrazoles; Time Factors | 2018 |
Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status.
Topics: Age Factors; Antihypertensive Agents; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Renal Insufficiency, Chronic; Tetrazoles; Treatment Outcome | 2017 |
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arterial Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome | 2018 |
Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypertension; Imidazoles; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2019 |
Effectiveness of the fixed-dose combination of olmesartan/amlodipine/hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD.
Topics: Age Factors; Amlodipine; Cardiovascular Diseases; Diabetes Complications; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Renal Insufficiency, Chronic; Tetrazoles | 2013 |
Recent progress in the treatment of cardiovascular disease using olmesartan.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Coronary Stenosis; Disease Models, Animal; Humans; Hypertension; Imidazoles; Plaque, Atherosclerotic; Tetrazoles | 2014 |
Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Endothelium, Vascular; Evidence-Based Medicine; Humans; Hypertension; Imidazoles; Meta-Analysis as Topic; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Tetrazoles | 2013 |
Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Ramipril; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome | 2014 |
Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation.
Topics: Amides; Antihypertensive Agents; Benzimidazoles; Benzopyrans; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Control Groups; Double-Blind Method; Drug Resistance; Eplerenone; Ethanolamines; Fumarates; Humans; Hypertension; Imidazoles; Kidney; Nebivolol; Oxadiazoles; Placebo Effect; Placebos; Randomized Controlled Trials as Topic; Regression Analysis; Research Design; Spironolactone; Sympathectomy; Tetrazoles; Treatment Outcome | 2015 |
[Up-to-Date Aspects of Antihypertensive Therapy from the Viewpoint of Cardio- and Nephroprotective Action: Olmesartan].
Topics: Angiotensin II Type 1 Receptor Blockers; Cardiotonic Agents; Humans; Hypertension; Imidazoles; Tetrazoles | 2015 |
A literature review to evaluate the clinical and economic value of olmesartan for the treatment of hypertensive patients.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Cost-Benefit Analysis; Humans; Hypertension; Imidazoles; Tetrazoles; Treatment Outcome | 2016 |
Adding Water to the Mill: Olmesartan-Induced Collagenous Sprue-A Case Report and Brief Literature Review.
Topics: Aged; Antihypertensive Agents; Collagenous Sprue; Diarrhea; Humans; Hypertension; Imidazoles; Male; Tetrazoles; Withholding Treatment | 2016 |
Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature.
Topics: Aged; Antihypertensive Agents; Atrophy; Biopsy; Collagenous Sprue; Diarrhea; Duodenum; Humans; Hypertension; Imidazoles; Male; Tetrazoles; Vomiting; Weight Loss | 2016 |
Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combination.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Drug Combinations; Humans; Hypertension; Imidazoles; Patient Compliance; Tablets; Tetrazoles | 2008 |
Olmesartan/Amlodipine: combination therapy for the treatment of hypertension [corrected].
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Imidazoles; Medication Adherence; Tetrazoles | 2009 |
Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Practice Guidelines as Topic; Severity of Illness Index; Tetrazoles; Time Factors; Treatment Outcome | 2008 |
Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Dose-Response Relationship, Drug; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
Beating the clock: reducing cardiovascular risk by rapid blood pressure reduction with olmesartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Cardiovascular Diseases; Humans; Hypertension; Imidazoles; Risk Reduction Behavior; Tetrazoles | 2010 |
Role of olmesartan in combination therapy in blood pressure control and vascular function.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Blood Vessels; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Tetrazoles | 2010 |
Efficacy and tolerability of olmesartan/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure control.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Severity of Illness Index; Tetrazoles | 2010 |
Olmesartan/amlodipine: a review of its use in the management of hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Evidence-Based Medicine; Humans; Hypertension; Imidazoles; Tetrazoles; Treatment Outcome | 2011 |
Angiotensin II receptor blocker combinations: from guidelines to clinical practice.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Antineoplastic Agents; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Medication Adherence; Practice Guidelines as Topic; Tetrazoles | 2012 |
[Multicenter trial of olmesartan. Main results].
Topics: Angiotensin II Type 1 Receptor Blockers; Humans; Hypertension; Imidazoles; Multicenter Studies as Topic; Tetrazoles; Treatment Outcome | 2011 |
[Recent advance in kidney and hypertension research].
Topics: Albuminuria; Amides; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Agonists; Catheter Ablation; Cerebrovascular Circulation; Chronic Disease; Diabetic Nephropathies; Drug Therapy, Combination; Evidence-Based Medicine; Fumarates; Humans; Hypertension; Imidazoles; Kidney; Kidney Diseases; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan | 2012 |
Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Tetrazoles | 2012 |
Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Hypertension, Renal; Imidazoles; Interleukin-6; Obesity; Prospective Studies; Publication Bias; Randomized Controlled Trials as Topic; Stents; Telmisartan; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2013 |
Population pharmacokinetics of olmesartan following oral administration of its prodrug, olmesartan medoxomil: in healthy volunteers and hypertensive patients.
Topics: Administration, Oral; Adult; Angiotensin II Type 1 Receptor Blockers; Creatinine; Europe; Female; Healthy Volunteers; Humans; Hypertension; Imidazoles; Japan; Linear Models; Male; Middle Aged; Models, Biological; Olmesartan Medoxomil; Prodrugs; Retrospective Studies; Tetrazoles; United States | 2005 |
The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Desoxycorticosterone; Diabetes Mellitus; Diabetic Nephropathies; Hypertension; Imidazoles; Kidney; Rats; Rats, Inbred SHR; Rats, Zucker; Tetrazoles | 2005 |
Treatment of hypertension with olmesartan medoxomil, alone and in combination with a diuretic: an update.
Topics: Angiotensin II Type 1 Receptor Blockers; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Tetrazoles | 2007 |
[ARB: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Contraindications; Heart Failure; Humans; Hypertension; Imidazoles; Losartan; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |
137 trial(s) available for olmesartan and Blood Pressure, High
| Article | Year |
|---|---|
Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study.
Topics: Aminobutyrates; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Essential Hypertension; Humans; Hypertension; Imidazoles; Japan; Tetrazoles; Treatment Outcome; Valsartan | 2022 |
Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation.
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Essential Hypertension; Humans; Hypertension; Inflammation; Middle Aged | 2023 |
Twenty-Four-Hour Blood Pressure-Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double-Blind Mult
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; East Asian People; Essential Hypertension; Humans; Hypertension; Tetrazoles; Valsartan | 2023 |
Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Tetrazoles; Treatment Outcome | 2021 |
Comparison of Efficacy and Safety of Azilsartan and Olmesartan in Patients With Essential Hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Blood Pressure; Dose-Response Relationship, Drug; Essential Hypertension; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Oxadiazoles; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome | 2017 |
Efficacy and Safety of Sacubitril/Valsartan (LCZ696) Compared With Olmesartan in Elderly Asian Patients (≥65 Years) With Systolic Hypertension.
Topics: Aged; Aged, 80 and over; Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Asian People; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Imidazoles; Male; Tetrazoles; Treatment Outcome; Valsartan | 2017 |
A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Chlorthalidone; Diuretics; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Oxadiazoles; Tetrazoles | 2018 |
Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Combinations; Drug Monitoring; Drug Resistance; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valsartan | 2018 |
Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Black or African American; Chlorthalidone; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Oxadiazoles; Tetrazoles; United States; White People | 2018 |
Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study.
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Azetidinecarboxylic Acid; Calcium Channel Blockers; Diabetes Complications; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Imidazoles; Kidney Diseases; Male; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Tetrazoles; Young Adult | 2013 |
Impact of angiotensin II receptor blocker therapy (olmesartan or valsartan) on coronary atherosclerotic plaque volume measured by intravascular ultrasound in patients with stable angina pectoris.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Combined Modality Therapy; Coronary Artery Disease; Disease Progression; Double-Blind Method; Female; Humans; Hypertension; Image Interpretation, Computer-Assisted; Imidazoles; Long-Term Care; Male; Middle Aged; Tetrazoles; Ultrasonography, Interventional; Valine; Valsartan | 2013 |
Efficacy and tolerability between an olmesartan/amlodipine fixed-dose combination and an amlodipine double dose in mild to moderate hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2013 |
Antihypertensive response to combination of olmesartan and amlodipine does not depend on method and time of drug administration.
Topics: Amlodipine; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Chi-Square Distribution; Circadian Rhythm; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Female; Humans; Hypertension; Hypoglycemic Agents; Imidazoles; Italy; Male; Medication Adherence; Middle Aged; Monte Carlo Method; Single-Blind Method; Tetrazoles; Time Factors; Treatment Outcome | 2013 |
Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial.
Topics: Aged; Amlodipine; Azetidinecarboxylic Acid; Diastole; Dihydropyridines; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Middle Aged; Pulse Wave Analysis; Tetrazoles; Vascular Stiffness; Ventricular Function, Left | 2013 |
Supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial--rationale and design.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Imidazoles; Prospective Studies; Tetrazoles; Treatment Outcome | 2013 |
Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapies.
Topics: Adipokines; Amlodipine; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Inflammation; Insulin; Insulin Resistance; Interleukin-10; Interleukin-8; Lipids; Male; Middle Aged; Tetrazoles | 2013 |
Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Diabetes Complications; Female; Heart Rate; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Tetrazoles; Time Factors | 2013 |
Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation.
Topics: Amlodipine; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Imidazoles; Inflammation; Insulin Resistance; Lipids; Male; Middle Aged; Tetrazoles | 2014 |
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hypertension; Imidazoles; Inflammation; Insulin Resistance; Lipids; Male; Middle Aged; Tetrazoles | 2014 |
Effects of dual blockade of the renin-angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT-Hypertension).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Imidazoles; Kaplan-Meier Estimate; Kidney Function Tests; Male; Middle Aged; Regression Analysis; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2013 |
Daytime systolic ambulatory blood pressure with a direct switch between candesartan monotherapy and the fixed-dose combination olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-1).
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Systole; Tetrazoles; Treatment Outcome | 2013 |
Combining rosuvastatin with angiotensin-receptor blockers of different PPARγ-activating capacity: effects on high-density lipoprotein subfractions and associated enzymes.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Angiotensin II Type 1 Receptor Blockers; Aryldialkylphosphatase; Benzimidazoles; Benzoates; Biomarkers; Biphenyl Compounds; Cholesterol, HDL; Drug Therapy, Combination; Dyslipidemias; Female; Fluorobenzenes; Greece; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Irbesartan; Lipoproteins, HDL; Male; Middle Aged; PPAR gamma; Prediabetic State; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Telmisartan; Tetrazoles; Treatment Outcome | 2015 |
Effects of combination therapy with olmesartan and azelnidipine on serum osteoprotegerin in patients with hypertension.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Azetidinecarboxylic Acid; Biomarkers; Blood Pressure; C-Reactive Protein; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Matrix Metalloproteinase 2; Middle Aged; Osteoprotegerin; Prospective Studies; Tetrazoles | 2014 |
The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertension.
Topics: Adult; Aged; Amlodipine; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Middle Aged; Multivariate Analysis; Perindopril; Risk Assessment; Tetrazoles; Treatment Outcome | 2013 |
Daytime systolic ambulatory blood pressure with a two-step switch from candesartan to olmesartan monotherapy and the fixed-dose combination of olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-2).
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome; White People | 2014 |
Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study.
Topics: Aged; Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Double-Blind Method; Drug Combinations; Drug Monitoring; Female; Hemodynamics; Humans; Hypertension; Imidazoles; Male; Middle Aged; Neprilysin; Prospective Studies; Research Design; Tetrazoles; Treatment Outcome; Valsartan; Vascular Stiffness | 2014 |
Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study.
Topics: Age Factors; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Asian People; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Japan; Male; Prospective Studies; Risk Factors; Sex Factors; Tetrazoles; Treatment Outcome | 2014 |
Difference in the effects of switching from candesartan to olmesartan or telmisartan to olmesartan in hypertensive patients with type 2 diabetes: the COTO study.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Telmisartan; Tetrazoles | 2014 |
Open-label study assessing the long-term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertension.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Time; Treatment Outcome | 2014 |
Effect of antihypertensive therapy on endothelial markers in newly diagnosed stage 1 hypertension: a randomized single-centre study.
Topics: Antihypertensive Agents; Blood Pressure; C-Reactive Protein; Humans; Hypertension; Imidazoles; Male; Middle Aged; Nebivolol; Nitric Oxide; Plasminogen Activator Inhibitor 1; Tetrazoles; Treatment Outcome; Turkey; Vasodilation | 2014 |
Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Retreatment; Tetrazoles; Treatment Outcome | 2014 |
Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Incidence; Japan; Male; Prospective Studies; Stroke; Tetrazoles | 2014 |
Dose-dependent arterial destiffening and inward remodeling after olmesartan in hypertensives with metabolic syndrome.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Carotid Arteries; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Metabolic Syndrome; Middle Aged; Pulse Wave Analysis; Tetrazoles; Treatment Outcome; Vascular Stiffness | 2014 |
Efficacy and tolerability of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide: a subgroup analysis of patients stratified by hypertension severity, age, sex, and obesity.
Topics: Adult; Age Factors; Aged; Amlodipine; Blood Pressure; Body Mass Index; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Sex Factors; Tetrazoles | 2014 |
Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Tetrazoles; Treatment Outcome | 2015 |
Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Tetrazoles | 2015 |
Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial.
Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Diet, Sodium-Restricted; Female; Food; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Patient Education as Topic; Renal Insufficiency, Chronic; Single-Blind Method; Sodium; Sodium, Dietary; Surveys and Questionnaires; Tetrazoles | 2014 |
Differential effectiveness of ARB plus CCB therapy and high-dose ARB therapy in high-risk elderly hypertensive patients: subanalysis of the OSCAR study.
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endpoint Determination; Female; Glomerular Filtration Rate; Humans; Hypertension; Imidazoles; Japan; Male; Prospective Studies; Risk Factors; Tetrazoles; Treatment Outcome | 2015 |
Angiotensin II receptor blockade and skeletal muscle metabolism in overweight and obese adults with elevated blood pressure.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Body Mass Index; Fatty Acids; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Muscle, Skeletal; Obesity; Tetrazoles; Young Adult | 2015 |
Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Imidazoles; Kaplan-Meier Estimate; Male; Medication Adherence; Prospective Studies; Tetrazoles; Treatment Outcome | 2015 |
[Corrective effect of olmesartan on parameters of the local rigidity using the echo-tracking technology].
Topics: Adult; Antihypertensive Agents; Carotid Arteries; Carotid Intima-Media Thickness; Coronary Artery Disease; Drug Monitoring; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Reproducibility of Results; Tetrazoles; Treatment Outcome; Vascular Stiffness | 2014 |
Different chronotherapeutic effects of valsartan and olmesartan in non-dipper hypertensive patients during valsartan treatment at morning.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Creatinine; Drug Chronotherapy; Female; Glomerular Filtration Rate; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Valsartan | 2015 |
A multicenter, non-comparative study to evaluate the efficacy and safety of fixed-dose olmesartan/amlodipine in Korean patients with hypertension who are naïve or non-responders to anti-hypertensive monotherapy (ACE-HY study).
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Incidence; Male; Middle Aged; Prospective Studies; Republic of Korea; Tetrazoles; Treatment Outcome | 2015 |
Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension.
Topics: Adult; Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Quality of Life; Tetrazoles; Treatment Outcome | 2015 |
Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis.
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Risk Factors; Tetrazoles | 2015 |
Urinary adiponectin and albuminuria in non-diabetic hypertensive patients: an analysis of the ESPECIAL trial.
Topics: Adiponectin; Adult; Albuminuria; Antihypertensive Agents; Creatinine; Diet Therapy; Female; Humans; Hypertension; Imidazoles; Linear Models; Logistic Models; Male; Middle Aged; Odds Ratio; Patient Education as Topic; Tetrazoles | 2015 |
Fixed-Combination Olmesartan/Amlodipine Was Superior to Perindopril + Amlodipine in Reducing Central Systolic Blood Pressure in Hypertensive Patients With Diabetes.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Tetrazoles; Treatment Outcome | 2016 |
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Practice Guidelines as Topic; Ramipril; Tetrazoles; Treatment Outcome | 2015 |
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Essential Hypertension; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Perindopril; Tetrazoles; Treatment Outcome | 2016 |
Olmesartan Combined With Amlodipine on Oxidative Stress Parameters in Type 2 Diabetics, Compared With Single Therapies: A Randomized, Controlled, Clinical Trial.
Topics: Adult; Amlodipine; Antihypertensive Agents; Aryldialkylphosphatase; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Imidazoles; Isoprostanes; Male; Oxidative Stress; Peroxidase; Tetrazoles | 2016 |
Changeover Trial of Azilsartan and Olmesartan Comparing Effects on the Renin-Angiotensin-Aldosterone System in Patients with Essential Hypertension after Cardiac Surgery (CHAOS Study).
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Blood Pressure; Cardiac Surgical Procedures; Drug Substitution; Essential Hypertension; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Japan; Male; Middle Aged; Oxadiazoles; Prospective Studies; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Remodeling | 2016 |
Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Missed Dose in Type 2 Diabetes.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Pulse Wave Analysis; Tetrazoles | 2016 |
The Impact of Azilsartan Medoxomil Treatment (Capsule Formulation) at Doses Ranging From 10 to 80 mg: Significant, Rapid Reductions in Clinic Diastolic and Systolic Blood Pressure.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Oxadiazoles; Tetrazoles; Treatment Outcome | 2017 |
Influence of Left Ventricular Ejection Fraction on the Effects of Supplemental Use of Angiotensin Receptor Blocker Olmesartan in Hypertensive Patients With Heart Failure.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Imidazoles; Kidney; Male; Middle Aged; Prospective Studies; Stroke Volume; Survival Rate; Tetrazoles | 2016 |
Data mining experiments on the Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF-AFNET 2) trial: 'exposing the invisible'.
Topics: Age Distribution; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Comorbidity; Data Mining; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Incidence; Male; Middle Aged; Prevalence; Risk Factors; Sex Distribution; Tetrazoles; Treatment Outcome; Turkey | 2017 |
Practical efficacy of olmesartan versus azilsartan in patients with hypertension: a multicenter randomized-controlled trial (MUSCAT-4 study).
Topics: Aged; Benzimidazoles; Blood Pressure; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Oxadiazoles; Tetrazoles | 2017 |
Comparison of the effects of telmisartan and olmesartan on home blood pressure, glucose, and lipid profiles in patients with hypertension, chronic heart failure, and metabolic syndrome.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Chronic Disease; Female; Glycated Hemoglobin; Heart Failure; Heart Rate; Humans; Hypertension; Imidazoles; Lipid Metabolism; Lipids; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Natriuretic Peptide, Brain; Telmisartan; Tetrazoles | 2008 |
Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Benzimidazoles; Benzoates; Fatty Liver; Female; Hepatitis C, Chronic; Homeostasis; Humans; Hypertension; Imidazoles; Incidence; Insulin Resistance; Japan; Male; Middle Aged; Pilot Projects; Telmisartan; Tetrazoles | 2008 |
Olmesartan reduced microalbuminuria in Japanese subjects with type 2 diabetes.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Asian People; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Telmisartan; Tetrazoles; Valine; Valsartan | 2009 |
Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Atenolol; Carotid Arteries; Carotid Artery Diseases; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Pilot Projects; Tetrazoles; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography | 2007 |
Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Drug Administration Schedule; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles | 2009 |
Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Cohort Studies; Drug Combinations; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Patient Compliance; Prospective Studies; Tetrazoles; Valine; Valsartan | 2009 |
Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Diuretics; Double-Blind Method; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Hypertension; Imidazoles; Japan; Male; Prospective Studies; Risk; Tetrazoles | 2009 |
Effects of angiotensin II receptor blockers on relationships between 24-hour blood pressure, autonomic function, and health-related QOL.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Autonomic Nervous System; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Circadian Rhythm; Dose-Response Relationship, Drug; Female; Health Surveys; Heart Rate; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Quality of Life; Telmisartan; Tetrazoles; Valine; Valsartan | 2009 |
Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin.
Topics: Adult; Aged; Angiopoietin-2; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; C-Reactive Protein; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Male; Middle Aged; Pravastatin; Prospective Studies; Tetrazoles; Vasculitis | 2009 |
Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combina
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Data Interpretation, Statistical; Drug Therapy, Combination; Endpoint Determination; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Informed Consent; Japan; Male; Patient Selection; Random Allocation; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Sample Size; Tetrazoles | 2009 |
Comparison of olmesartan medoxomil versus amlodipine besylate on regression of ventricular and vascular hypertrophy.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diastole; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Middle Aged; Tetrazoles; Time Factors; Treatment Outcome | 2009 |
Olmesartan ameliorates myocardial function independent of blood pressure control in patients with mild-to-moderate hypertension.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Blood Pressure; C-Reactive Protein; Calcium Channel Blockers; Echocardiography, Doppler, Color; Female; Fibrosis; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Inflammation; Male; Middle Aged; Myocardium; Severity of Illness Index; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Function, Left | 2009 |
Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aorta; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Japan; Male; Middle Aged; Prospective Studies; Single-Blind Method; Tetrazoles; Time Factors; Treatment Outcome | 2009 |
24-hour and nighttime blood pressures in type 2 diabetic hypertensive patients following morning or evening administration of olmesartan.
Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Circadian Rhythm; Creatinine; Cross-Over Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles | 2009 |
Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.
Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Ankle Brachial Index; Azetidinecarboxylic Acid; Blood Pressure; C-Reactive Protein; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Diuretics; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Imidazoles; Lipoproteins, LDL; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Tetrazoles; Trichlormethiazide | 2009 |
Comparative pharmacodynamics of olmesartan and azelnidipine in patients with hypertension: a population pharmacokinetic/pharmacodynamic analysis.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Clinical Laboratory Techniques; Cross-Over Studies; Dihydropyridines; Female; Humans; Hypertension; Imidazoles; Individuation; Male; Middle Aged; Olmesartan Medoxomil; Population Groups; Tetrazoles | 2009 |
Benefits of the angiotensin II receptor antagonist olmesartan in controlling hypertension and cerebral hemodynamics after stroke.
Topics: Acetazolamide; Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Circulation; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Stroke; Stroke Rehabilitation; Tetrazoles; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2009 |
Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Ankle; Antihypertensive Agents; Body Weight; Calcium Channel Blockers; Deoxyguanosine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypertension; Imidazoles; Lipids; Male; Middle Aged; Tetrazoles | 2009 |
Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Middle Aged; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Tetrazoles | 2010 |
Effects of angiotensin II receptor blockers on the relationships between ambulatory blood pressure and anti-hypertensive effects, autonomic function, and health-related quality of life.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Heart Rate; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Quality of Life; Sympathetic Nervous System; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2009 |
Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes.
Topics: Aged; Algorithms; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Time Factors | 2010 |
Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine.
Topics: Aged; Aged, 80 and over; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Renal Insufficiency, Chronic; Tetrazoles | 2010 |
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension.
Topics: Age Factors; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Black or African American; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; United States; Vasodilator Agents | 2010 |
Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients.
Topics: Adult; Aged; Amlodipine; Ankle Joint; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Drug Therapy, Combination; Edema; Female; Heart Rate; Humans; Hypertension; Imidazoles; Male; Middle Aged; Norepinephrine; Prospective Studies; Tetrazoles; Valine; Valsartan | 2010 |
Clinical and pharmacotherapeutic relevance of the double-chain domain of the angiotensin II type 1 receptor blocker olmesartan.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Animals; Binding Sites; Blood Pressure; Female; Heart Rate; Humans; Hydrogen Bonding; Hypertension; Imidazoles; Male; Middle Aged; Models, Molecular; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Renal Insufficiency, Chronic; Static Electricity; Tetrazoles | 2010 |
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; C-Reactive Protein; Drug Therapy, Combination; Fasting; Female; Fluorobenzenes; Greece; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Imidazoles; Insulin; Irbesartan; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Telmisartan; Tetrazoles | 2010 |
The angiotensin II type 1 receptor antagonist olmesartan preserves cerebral blood flow and cerebrovascular reserve capacity, and accelerates rehabilitative outcomes in hypertensive patients with a history of stroke.
Topics: Acetazolamide; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Brain; Female; Hemodynamics; Humans; Hypertension; Imidazoles; Male; Middle Aged; Regional Blood Flow; Stroke; Stroke Rehabilitation; Tetrazoles; Treatment Outcome | 2010 |
Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients.
Topics: Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Female; Glycemic Index; Humans; Hypertension; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Male; Middle Aged; Tetrazoles | 2010 |
Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome; United States; Vasodilator Agents | 2010 |
Strong suppression of the renin-angiotensin system has a renal-protective effect in hypertensive patients: high-dose ARB with ACE inhibitor (Hawaii) study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Female; Hawaii; Humans; Hypertension; Imidazoles; Imidazolidines; Kidney; Kidney Diseases; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2010 |
The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Creatinine; Drug Chronotherapy; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2010 |
Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2010 |
Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Cholesterol; Cytokines; Female; Humans; Hypertension; Imidazoles; Insulin; Irbesartan; Middle Aged; Nicotinamide Phosphoribosyltransferase; Obesity; Prospective Studies; Spain; Tetrazoles; Time Factors; Treatment Outcome; Triglycerides | 2010 |
Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Ankle Brachial Index; Antihypertensive Agents; Arteries; Biomarkers; Blood Pressure; C-Reactive Protein; Down-Regulation; Elasticity; Fatty Acid-Binding Proteins; Female; Humans; Hypertension; Imidazoles; Japan; Linear Models; Male; Middle Aged; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome | 2011 |
Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study.
Topics: Adiponectin; Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; C-Reactive Protein; Comorbidity; Cytokines; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Incidence; Insulin Resistance; Intercellular Adhesion Molecule-1; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Single-Blind Method; Tetrazoles; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 2011 |
Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension.
Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Cholesterol, HDL; Creatinine; Dihydropyridines; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Imidazoles; Male; Sodium Chloride Symporter Inhibitors; Tetrazoles; Treatment Outcome | 2011 |
Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asia; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Europe; Female; Humans; Hypertension; Hypoglycemic Agents; Imidazoles; Male; Middle Aged; Office Visits; Predictive Value of Tests; Regression Analysis; Risk Assessment; Risk Factors; Tetrazoles; United States; Young Adult | 2011 |
The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure.
Topics: Aged; Angiotensin Receptor Antagonists; Argentina; Benzimidazoles; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Mexico; Middle Aged; Oxadiazoles; Peru; Racial Groups; Tetrazoles; Treatment Outcome; United States | 2011 |
Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension.
Topics: Adult; Aged; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Oxadiazoles; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2011 |
Olmesartan improves endothelial function in hypertensive patients: link with extracellular superoxide dismutase.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; C-Reactive Protein; Cross-Over Studies; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Superoxide Dismutase; Tetrazoles; Vasodilation | 2011 |
Design and rationale of Japanese evaluation between Formula of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study (J-FLAG) : evaluation of the antialbuminuric effects between calcium channel blocker with sympatholytic action
Topics: Adult; Aged; Albuminuria; Amlodipine; Azetidinecarboxylic Acid; Calcium Channel Blockers; Diabetic Nephropathies; Dihydropyridines; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Middle Aged; Research Design; Sympatholytics; Tetrazoles | 2011 |
A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Blockers; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Self Report; Tetrazoles; Titrimetry; Young Adult | 2011 |
Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria.
Topics: Aged; Albuminuria; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles | 2011 |
Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Chi-Square Distribution; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Japan; Male; Middle Aged; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography | 2011 |
Effects of olmesartan on the renin-angiotensin-aldosterone system for patients with essential hypertension after cardiac surgery--investigation using a candesartan change-over study.
Topics: Aged; Aldosterone; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arteries; Benzimidazoles; Biphenyl Compounds; Cardiac Surgical Procedures; Compliance; Drug Substitution; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Japan; Male; Middle Aged; Prospective Studies; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome | 2011 |
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hyperkalemia; Hypertension; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Stroke; Tetrazoles; Treatment Outcome | 2011 |
Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amides; Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Resistance; Drug Substitution; Female; Fumarates; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tablets; Tetrazoles; Treatment Failure; Treatment Outcome; Young Adult | 2012 |
24-hour efficacy and safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudy.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Time Factors | 2011 |
Effect of switching from telmisartan, valsartan, olmesartan, or losartan to candesartan on morning hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; Hypertension; Imidazoles; Japan; Losartan; Male; Middle Aged; Prospective Studies; Telmisartan; Tetrazoles; Valine; Valsartan | 2012 |
Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2012 |
Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Time Factors | 2012 |
Prevention of microalbuminuria in patients with type 2 diabetes and hypertension.
Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2012 |
Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Japan; Male; Prospective Studies; Single-Blind Method; Survival Analysis; Tetrazoles; Treatment Outcome | 2012 |
Effect of nisoldipine and olmesartan on endothelium-dependent vasodilation in essential hypertensive patients.
Topics: Aged; Anthracenes; Antihypertensive Agents; Arginine; Blood Pressure; C-Reactive Protein; Case-Control Studies; Endothelin-1; Endothelium; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Nisoldipine; Nitric Oxide; Propane; Prostaglandins F; Single-Blind Method; Tetrazoles; Vasodilation | 2012 |
Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretic
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Azetidinecarboxylic Acid; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Tetrazoles; Treatment Outcome | 2012 |
Comparison of the efficacy and safety of irbesartan and olmesartan in patients with hypertension (EARTH study).
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Female; Humans; Hypertension; Imidazoles; Irbesartan; Male; Middle Aged; Tetrazoles | 2012 |
Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in elderly hypertensive patients: pooled individual data analysis of two randomized, double-blind, parallel-group studies.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Office Visits; Placebos; Ramipril; Tetrazoles | 2012 |
Association of changes in ambulatory arterial stiffness index and pulse wave velocity during antihypertensive treatment: the J-CORE study.
Topics: Aged; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Pulse Wave Analysis; Tetrazoles; Vascular Stiffness | 2012 |
Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Black People; Blood Pressure; Chlorthalidone; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Oxadiazoles; Severity of Illness Index; Tetrazoles; Treatment Outcome; White People | 2012 |
The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: the OLCA study.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Azetidinecarboxylic Acid; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Chi-Square Distribution; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Therapy, Combination; Female; Glycated Hemoglobin; Heart Rate; Humans; Hypertension; Imidazoles; Japan; Male; Middle Aged; Tetrazoles; Time Factors; Treatment Outcome | 2012 |
Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Comorbidity; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Ethnicity; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles | 2012 |
Reduction of the morning blood pressure surge treated with olmesartan in Chinese patients with mild to moderate essential hypertension--a multicenter, open-label, single treatment group clinical study.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Asian People; Blood Pressure; Blood Pressure Monitoring, Ambulatory; China; Circadian Rhythm; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Tetrazoles; Time Factors; Treatment Outcome; Young Adult | 2012 |
Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Black People; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles | 2012 |
Olmesartan improves coronary flow reserve of hypertensive patients using coronary magnetic resonance imaging compared with amlodipine.
Topics: Adenosine; Adult; Aged; Amlodipine; Antihypertensive Agents; Coronary Circulation; Echocardiography; Female; Humans; Hypertension; Imidazoles; Magnetic Resonance Angiography; Male; Middle Aged; Stroke Volume; Tetrazoles; Vasodilator Agents; Ventricular Function, Left | 2012 |
Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
Topics: Adult; Aged; Aging; Amlodipine; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Young Adult | 2012 |
Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Body Mass Index; Body Weight; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Insulin Resistance; Lipids; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2013 |
Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study.
Topics: Aged; Albuminuria; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardio-Renal Syndrome; Circadian Rhythm; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2013 |
Effects of manidipine plus rosuvastatin versus olmesartan plus rosuvastatin on markers of insulin resistance in patients with impaired fasting glucose, hypertension, and mixed dyslipidemia.
Topics: Aged; Blood Glucose; Dihydropyridines; Drug Therapy, Combination; Dyslipidemias; Endpoint Determination; Fasting; Female; Fluorobenzenes; Humans; Hypertension; Imidazoles; Insulin Resistance; Male; Middle Aged; Nitrobenzenes; Piperazines; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Single-Blind Method; Sulfonamides; Tetrazoles; Treatment Outcome | 2013 |
The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Collagen Type IV; Comorbidity; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Imidazoles; Kidney; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Tetrazoles | 2013 |
Effects of an olmesartan/amlodipine fixed dose on blood pressure control, some adipocytokines and interleukins levels compared with olmesartan or amlodipine monotherapies.
Topics: Adipokines; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Interleukins; Male; Middle Aged; Tetrazoles; Time Factors | 2013 |
Antihypertensive and metabolic effects of high-dose olmesartan and telmisartan in type 2 diabetes patients with hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzimidazoles; Benzoates; C-Reactive Protein; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Resistance; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Male; Middle Aged; Telmisartan; Tetrazoles | 2013 |
Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure.
Topics: Angiotensin Receptor Antagonists; Biopsy; Cross-Over Studies; Female; Glucose Tolerance Test; Humans; Hypertension; Imidazoles; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Obesity; Overweight; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2013 |
Comparative effect of candesartan and amlodipine, and effect of switching from valsartan, losartan, telmisartan and olmesartan to candesartan, on early morning hypertension and heart rate.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Drug Substitution; Female; Heart Rate; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Prospective Studies; Telmisartan; Tetrazoles; Valine; Valsartan | 2013 |
Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Case-Control Studies; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prognosis; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Survival Rate; Tetrazoles; Young Adult | 2013 |
Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Severity of Illness Index; Single-Blind Method; Tetrazoles; Treatment Outcome | 2005 |
Prevention of migraine with olmesartan in patients with hypertension/prehypertension.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Migraine Disorders; Tetrazoles | 2006 |
Blood pressure reduction with olmesartan in mild-to-moderate essential hypertension: a planned interim analysis of an open label sub-study in German patients.
Topics: Adolescent; Adult; Aged; Angiotensin Receptor Antagonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles | 2006 |
Efficacy and safety of treating stage 2 systolic hypertension with olmesartan and olmesartan/HCTZ: results of an open-label titration study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Single-Blind Method; Tetrazoles; Treatment Outcome | 2007 |
Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Circadian Rhythm; Diastole; Drug Administration Schedule; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Systole; Tetrazoles; Treatment Outcome | 2007 |
Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Female; Fibrinogen; Glucose Clamp Technique; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Indans; Insulin Resistance; Male; Middle Aged; Nitrobenzenes; Obesity; Piperazines; Tetrazoles | 2008 |
Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Complications; Diabetes Mellitus, Type 2; Dihydropyridines; Diuretics; Drug Combinations; Endpoint Determination; Female; Humans; Hydrochlorothiazide; Hypertension; Hypotension, Orthostatic; Imidazoles; Indans; Male; Nitrobenzenes; Piperazines; Posture; Prospective Studies; Tetrazoles | 2008 |
158 other study(ies) available for olmesartan and Blood Pressure, High
| Article | Year |
|---|---|
Safety and cardiovascular effectiveness of olmesartan in combination therapy for advanced hypertension: an electronic health record-based cohort study.
Topics: Antihypertensive Agents; Cohort Studies; Electronic Health Records; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Tetrazoles | 2023 |
Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Combinations; Female; Heart Disease Risk Factors; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Olmesartan Medoxomil; Prospective Studies; Republic of Korea; Risk Factors; Tetrazoles | 2023 |
Liver injury related to olmesartan-associated sprue-like enteropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Chemical and Drug Induced Liver Injury; Diarrhea; Humans; Hypertension; Imidazoles; Liver; Malabsorption Syndromes; Male; Middle Aged; Tetrazoles | 2019 |
Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture.
Topics: Aged, 80 and over; Antihypertensive Agents; Asthenia; Capsule Endoscopes; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Duodenum; Edema; Humans; Hypertension; Imidazoles; Intestinal Diseases; Male; Tetrazoles | 2020 |
Efficacy and safety of a combination antihypertensive drug (olmesartan plus azelnidipine): "Issues with hypertension studies in real-world practice".
Topics: Amlodipine; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Drug Combinations; Drug Substitution; Female; Humans; Hypertension; Imidazoles; Japan; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome | 2020 |
Olmesartan enteropathy: an important cause of malabsorption and diarrhoea.
Topics: Antihypertensive Agents; Atrophy; Celiac Disease; Diarrhea; Female; Humans; Hypertension; Imidazoles; Middle Aged; Tetrazoles | 2020 |
Drug-induced anti-Ro positive subacute cutaneous lupus in a man treated with olmesartan.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antibodies, Antinuclear; Humans; Hypertension; Imidazoles; Lupus Erythematosus, Cutaneous; Male; Skin; Tetrazoles | 2019 |
The effect of therapy with olmesartan or telmisartan in patients with arterial hypertension combined with obesity.
Topics: Blood Pressure; Humans; Hypertension; Imidazoles; Obesity; Telmisartan; Tetrazoles | 2020 |
[Impact of stopping reimbursement of olmesartan for hypertensive patients in primary care].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Female; France; Humans; Hypertension; Imidazoles; Insurance, Pharmaceutical Services; Male; Middle Aged; Primary Health Care; Reimbursement Mechanisms; Retrospective Studies; Tetrazoles | 2020 |
Olmesartan-associated duodenal villous atrophy, an emerging clinical issue.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles | 2020 |
Effectiveness of Olmesartan on Blood Pressure Control in Hypertensive Patients in India: A Real World, Retrospective, Observational Study from Electronic Medical Records.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Electronic Health Records; Humans; Hypertension; Imidazoles; India; Olmesartan Medoxomil; Retrospective Studies; Tetrazoles | 2020 |
[Effects of Olmesartan Medoxomil on Patients with Thoracic and Thoracoabdominal Aortic Aneurysm;Evaluation of Anti-hypertensive Effect and Possible Suppression of Aneurysmal Dilation( OLM 40 Study)].
Topics: Antihypertensive Agents; Aortic Aneurysm, Thoracic; Dilatation; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Prospective Studies; Tetrazoles | 2020 |
Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Hypertension; Imidazoles; Mesenteric Arteries; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Tetrazoles; Vascular Remodeling; Vasodilation | 2020 |
Acute hepatitis due to olmesartan: an uncommon entity.
Topics: Antihypertensive Agents; Blood Pressure; Female; Hepatitis; Humans; Hypertension; Imidazoles; Middle Aged; Tetrazoles | 2021 |
Olmesartan associated enteropathy. A multiface clinical and histological entity.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Colonic Diseases; Diarrhea; Humans; Hypertension; Imidazoles; Male; Tetrazoles | 2021 |
Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry Analysis.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Body Fluids; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Hypertension; Imidazoles; Liquid-Liquid Extraction; Metoprolol; Patient Compliance; Pilot Projects; Plasma; Reference Values; Reproducibility of Results; Tandem Mass Spectrometry; Tetrazoles | 2021 |
Efficacy of olmesartan amlodipine in Colombian hypertensive patients (soat study).
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Colombia; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Retrospective Studies; Tetrazoles; Treatment Outcome | 2017 |
Antihypertensive Drugs Aliskiren, Nebivolol, and Olmesartan Reduce Hypertension by Reducing Endothelial Microparticles and Regulating Angiogenesis.
Topics: Amides; Animals; Antihypertensive Agents; Cell-Derived Microparticles; Drug Therapy, Combination; Fumarates; Humans; Hypertension; Imidazoles; Male; Nebivolol; Neovascularization, Pathologic; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrazoles | 2017 |
Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
Topics: Administration, Oral; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Substitution; Female; Germany; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Pilot Projects; Tablets; Tetrazoles; Time Factors; Treatment Outcome | 2018 |
Response to Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment.
Topics: Humans; Hypertension; Imidazoles; Tetrazoles | 2017 |
Comments on: "Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension".
Topics: Blood Pressure; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Tetrazoles | 2017 |
Predictors for the development of microalbuminuria and interaction with renal function.
Topics: Adolescent; Adult; Aged; Albuminuria; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Imidazoles; Incidence; Kidney; Male; Middle Aged; Risk Factors; Tetrazoles; Young Adult | 2017 |
Advantages of sacubitril/valsartan beyond blood pressure control in arterial hypertension.
Topics: Aminobutyrates; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Combinations; Essential Hypertension; Humans; Hypertension; Imidazoles; Tetrazoles; Valsartan | 2017 |
Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Child; Child, Preschool; Cohort Studies; Diabetic Neuropathies; Esophageal Neoplasms; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Infant; Infant, Newborn; Losartan; Male; Middle Aged; Registries; Stomach Neoplasms; Survival Analysis; Tetrazoles; Young Adult | 2018 |
Treatment of hypertension in CKD patients with azilsartan/chlorthalidone vs olmesartan/hydrochlorothiazide.
Topics: Antihypertensive Agents; Benzimidazoles; Chlorthalidone; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Oxadiazoles; Renal Insufficiency, Chronic; Tetrazoles | 2018 |
Linalyl acetate prevents olmesartan-induced intestinal hypermotility mediated by interference of the sympathetic inhibitory pathway in hypertensive rat.
Topics: Animals; Blood Pressure; Body Weight; Cell Size; Epithelial Cells; Gastrointestinal Motility; Heart Rate; Hypertension; Imidazoles; Male; Monoterpenes; Neural Inhibition; Nitric Oxide; Nitrites; Nitroprusside; Norepinephrine; Rats, Sprague-Dawley; Sympathetic Nervous System; Tetrazoles; Vasodilation | 2018 |
Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Diuretics; Drug Resistance; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Mineralocorticoid Receptor Antagonists; Ramipril; Tetrazoles | 2018 |
Home blood pressure and cardiovascular outcomes in very elderly patients receiving antihypertensive drug therapy: a subgroup analysis of Home blood pressure measurement with Olmesartan Naive patients to Establish Standard Target blood pressure (HONEST) st
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Disorders; Female; Follow-Up Studies; Humans; Hypertension; Hypotension; Imidazoles; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Prospective Studies; Risk Factors; Risk Reduction Behavior; Systole; Tetrazoles | 2018 |
Olmesartan combined with renal denervation reduces blood pressure in association with sympatho-inhibitory and aldosterone-reducing effects in hypertensive mice with chronic kidney disease.
Topics: Albuminuria; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Combined Modality Therapy; Heart; Hypertension; Imidazoles; Kidney; Male; Mice; Mice, Inbred ICR; Nephrectomy; Organ Size; Renal Insufficiency, Chronic; Renin-Angiotensin System; Sympathectomy; Sympathetic Nervous System; Tetrazoles | 2019 |
The repercussion of stopping reimbursement of olmésartan on antihypertensive drugs prescription and blood pressure control of treated hypertensive patients in France.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Drug Prescriptions; Drug Substitution; Female; France; Humans; Hypertension; Imidazoles; Male; Middle Aged; Reimbursement Mechanisms; Self Report; Tetrazoles | 2018 |
New Onset Villous Atrophy in a Patient With Celiac Disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Biopsy; Celiac Disease; Collagenous Sprue; Diet, Gluten-Free; Female; Humans; Hypertension; Imidazoles; Intestine, Small; Medication Therapy Management; Microvilli; Risk Factors; Tetrazoles | 2018 |
Plantar Psoriasis Associated with Olmesartan.
Topics: Antihypertensive Agents; Female; Foot; Humans; Hypertension; Imidazoles; Middle Aged; Psoriasis; Tetrazoles | 2019 |
Olmesartan-associated severe gastritis and enteropathy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Diagnosis, Differential; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Humans; Hypertension; Imidazoles; Severity of Illness Index; Tetrazoles | 2018 |
Significant Weight Loss in a Patient Taking Olmesartan: An Unusual Case Report.
Topics: Aged; Antihypertensive Agents; Diarrhea; Female; Humans; Hypertension; Imidazoles; Tetrazoles; Weight Loss | 2019 |
Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterial Pressure; Blood Glucose; Brain; Capillaries; Cerebrovascular Circulation; Cerebrovascular Disorders; Coronary Circulation; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diet, High-Fat; Enalapril; Heart Ventricles; Hypertension; Imidazoles; Insulin; Leukocyte Rolling; Male; Microcirculation; Microscopy, Fluorescence; Microscopy, Video; Muscle, Skeletal; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Streptozocin; Tetrazoles | 2013 |
Renin angiotensin antagonists normalize aberrant activation of epithelial sodium channels in sodium-sensitive hypertension.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Down-Regulation; Epithelial Sodium Channels; Eplerenone; Hypertension; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Perindopril; Renin; Sodium; Sodium Chloride, Dietary; Spironolactone; Tetrazoles | 2012 |
Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Imidazoles; Kidney; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Thiazepines | 2013 |
[Hypertension. Goal: achieving target blood pressure with only 1 pill daily].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Germany; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Randomized Controlled Trials as Topic; Tetrazoles | 2013 |
Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress.
Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Disease Models, Animal; Hypertension; Imidazoles; Male; Malondialdehyde; Nerve Growth Factor; NF-E2-Related Factor 2; Nifedipine; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Wistar; Regional Blood Flow; Tetrazoles; Urinary Bladder; Urinary Bladder Diseases; Urodynamics | 2014 |
Enhanced blood pressure-lowering effect of olmesartan in hypertensive patients with chronic kidney disease-associated sympathetic hyperactivity: HONEST study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Sympathetic Nervous System; Tetrazoles; Young Adult | 2013 |
Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Austria; Blood Pressure; Diuretics; Drug Combinations; Energy Metabolism; Female; Germany; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Motor Activity; Tetrazoles; Time Factors; Treatment Outcome | 2013 |
Maintaining goal blood pressures after switching from olmesartan to other angiotensin receptor blockers.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Drug Substitution; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Retrospective Studies; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2013 |
[Influence of treatment with olmesartan on ambulatory blood pressure monitoring parameters in patients with arterial hypertension].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles | 2013 |
Peroxisome proliferator-activated receptor gamma concentrations in newly diagnosed hypertension patients and the metabolic effects of olmesartan.
Topics: Adult; Antihypertensive Agents; Case-Control Studies; Cholesterol; Female; Humans; Hypertension; Imidazoles; Male; Metabolic Syndrome; Middle Aged; PPAR gamma; Tetrazoles; Triglycerides; Waist Circumference | 2014 |
Examining the association of olmesartan and other angiotensin receptor blockers with overall and cause-specific mortality.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Cardiovascular Diseases; Cohort Studies; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Proportional Hazards Models; Registries; Retrospective Studies; Survival Rate; Taiwan; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2014 |
ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients.
Topics: Administration, Oral; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Medication Adherence; Risk Factors; Tablets; Tetrazoles; Treatment Outcome | 2014 |
Comparative effectiveness of olmesartan and other angiotensin receptor blockers in diabetes mellitus: retrospective cohort study.
Topics: Adult; Angiotensin Receptor Antagonists; Cardiovascular Diseases; Cohort Studies; Comorbidity; Diabetes Mellitus; Female; Gastrointestinal Diseases; Hospitalization; Humans; Hypertension; Imidazoles; Male; Middle Aged; Proportional Hazards Models; Registries; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Survival Rate; Tetrazoles; Treatment Outcome; United States | 2014 |
Olmesartan attenuates cardiac hypertrophy and improves cardiac diastolic function in spontaneously hypertensive rats through inhibition of calcineurin pathway.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Calcineurin; Cardiomegaly; Diastole; Down-Regulation; Fibrosis; Heart Rate; Hypertension; Imidazoles; Male; NFATC Transcription Factors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 2014 |
Cardiorenal protection in experimental hypertension with renal failure: comparison between vasopeptidase inhibition and angiotensin receptor blockade.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Rats, Wistar; Receptors, Angiotensin; Renal Insufficiency; Tetrazoles | 2015 |
Clinical impact of patient adherence to a fixed-dose combination of olmesartan, amlodipine and hydrochlorothiazide.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Essential Hypertension; Europe; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Prospective Studies; Risk Factors; Surveys and Questionnaires; Tetrazoles; Young Adult | 2014 |
Regulation of apelin and its receptor expression in adipose tissues of obesity rats with hypertension and cultured 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apelin; Apelin Receptors; Gene Expression; Gene Expression Regulation; Hypertension; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Obesity; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Tetrazoles | 2014 |
[Diarrhoea and malabsorption due to olmesartan use].
Topics: Antihypertensive Agents; Atrophy; Celiac Disease; Diagnosis, Differential; Diarrhea; Humans; Hypertension; Imidazoles; Male; Middle Aged; Netherlands; Olmesartan Medoxomil; Tetrazoles | 2014 |
Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Antihypertensive Agents; Biomarkers; Blood Pressure; Case-Control Studies; Female; Humans; Hypertension; Imidazoles; Japan; Kidney; Male; Middle Aged; Multivariate Analysis; Peptidyl-Dipeptidase A; Tetrazoles; Time Factors; Treatment Outcome; Up-Regulation | 2015 |
Impact of socio-economic factors on the long-term effectiveness of antihypertensive treatment with an angiotensin II receptor blocker: an observational study.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Female; Germany; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Risk Factors; Socioeconomic Factors; Tetrazoles; Time | 2014 |
[Enteropathy associated with chronic use of olmesartan].
Topics: Adenocarcinoma; Aged; Antihypertensive Agents; Atrophy; Celiac Disease; Chronic Disease; Diagnosis, Differential; Diagnostic Errors; Diarrhea; Duodenum; Humans; Hypertension; Imidazoles; Intestinal Mucosa; Malabsorption Syndromes; Male; Microvilli; Prostatectomy; Prostatic Neoplasms; Tetrazoles | 2015 |
[Hypertension. Guidelines recommend fixed combinations].
Topics: Amlodipine; Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Combinations; Guideline Adherence; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Medication Adherence; Randomized Controlled Trials as Topic; Tetrazoles | 2014 |
[Sprue-like enteropathy due to olmesartan: a case report].
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atrophy; Celiac Disease; Chronic Disease; Diarrhea; Female; Humans; Hypertension; Imidazoles; Intestinal Mucosa; Microvilli; Tetrazoles | 2015 |
Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade.
Topics: Aging; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Autonomic Nervous System; Baroreflex; beta-Galactosidase; Blood Pressure; Drug Evaluation, Preclinical; Endothelium, Vascular; Hypertension; Imidazoles; Myocardium; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Norepinephrine; Organ Size; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reflex, Abnormal; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Vasodilation | 2014 |
If I had resistant hypertension.
Topics: Amlodipine; Antihypertensive Agents; Atorvastatin; Blood Pressure; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Pyrroles; Spironolactone; Tetrazoles; Treatment Failure; Treatment Outcome | 2014 |
Blood pressure control and satisfaction of hypertensive patients following a switch to combined drugs of an angiotensin receptor blocker and a calcium channel blocker in clinical practice of nephrology.
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Azetidinecarboxylic Acid; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Drug Costs; Drug Substitution; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Nephrology; Patient Satisfaction; Practice Patterns, Physicians'; Renal Insufficiency, Chronic; Retrospective Studies; Surveys and Questionnaires; Telmisartan; Tetrazoles; Valsartan | 2015 |
Lipid and blood pressure control for the prevention of cardiovascular disease in hypertensive patients: a subanalysis of the OMEGA study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Dyslipidemias; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Lipids; Male; Middle Aged; Prognosis; Prospective Studies; Tetrazoles | 2015 |
[Enteropathy by olmesartan].
Topics: Aged; Antihypertensive Agents; Atrophy; Celiac Disease; Chronic Disease; Diagnosis, Differential; Diarrhea; Duodenum; Humans; Hypertension; Imidazoles; Immunophenotyping; Intestinal Mucosa; Lymphocyte Subsets; Malabsorption Syndromes; Male; Microvilli; Tetrazoles | 2015 |
Regression of glomerular and tubulointerstitial injuries by dietary salt reduction with combination therapy of angiotensin II receptor blocker and calcium channel blocker in Dahl salt-sensitive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Combined Modality Therapy; Cytokines; Diet, Sodium-Restricted; Dihydropyridines; Drug Evaluation, Preclinical; Gene Expression; Gene Expression Regulation; Hypertension; Imidazoles; Kidney Glomerulus; Male; NADPH Oxidases; Rats, Inbred Dahl; Receptors, Mineralocorticoid; Renal Insufficiency; Tetrazoles | 2014 |
Effect of angiotensin II receptor blocker, olmesartan, on turnover of bone metabolism in bedridden elderly hypertensive women with disuse syndrome.
Topics: Age Distribution; Aged; Aged, 80 and over; Analysis of Variance; Angiotensin Receptor Antagonists; Bone Density; Bone Resorption; Calcium Channel Blockers; Cohort Studies; Female; Follow-Up Studies; Geriatric Assessment; Humans; Hypertension; Imidazoles; Immobilization; Incidence; Japan; Osteoporosis; Prognosis; Risk Assessment; Tetrazoles | 2015 |
Safety of olmesartan in a patient with telmisartan-induced myotoxicity: a case report.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Substitution; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Male; Middle Aged; Myalgia; Telmisartan; Tetrazoles; Treatment Outcome | 2015 |
Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Propensity Score; Ramipril; Retrospective Studies; Risk Factors; Telmisartan; Tetrazoles | 2015 |
Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Austria; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Combinations; Female; Germany; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Primary Health Care; Prospective Studies; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome | 2015 |
[Optimizing antihypertensive therapy].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Metabolic Syndrome; Randomized Controlled Trials as Topic; Tetrazoles | 2015 |
Noninferiority studies with multiple reference treatments.
Topics: Benzimidazoles; Blood Pressure; Equivalence Trials as Topic; Humans; Hypertension; Imidazoles; Oxadiazoles; Reference Standards; Research Design; Sample Size; Tetrazoles; Treatment Outcome; Valsartan | 2017 |
Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Autophagy; Blood Pressure; Captopril; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; Drugs, Chinese Herbal; Gene Expression Regulation; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Metoprolol; Mice, Inbred C57BL; Myocytes, Cardiac; Signal Transduction; Tetrazoles; Ventricular Function, Left; Ventricular Remodeling | 2015 |
Differences in 24-h blood pressure profile of Japanese hypertensive patients under ARB treatment.
Topics: Aged; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Sectional Studies; Female; Humans; Hypertension; Imidazoles; Japan; Male; Middle Aged; Tetrazoles; Therapeutic Equivalency | 2015 |
[Enteropathy due to olmesartan].
Topics: Antihypertensive Agents; Atrophy; Biopsy; Diarrhea; Duodenitis; Duodenum; Essential Hypertension; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Withholding Treatment | 2016 |
Medication-taking behavior in hypertensive patients with a single-tablet, fixed-dose combination in Japan.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Azetidinecarboxylic Acid; Cohort Studies; Dihydropyridines; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Japan; Male; Medication Adherence; Middle Aged; Prospective Studies; Surveys and Questionnaires; Tablets; Tetrazoles | 2016 |
Differences between clinic blood pressure and morning home blood pressure, as shown by Bland-Altman plots, in a large observational study (HONEST study).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Blood Pressure Determination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Systole; Tetrazoles | 2015 |
Unusual Severe Side Effect of a Commonly Used Drug.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Humans; Hyperkalemia; Hypertension; Imidazoles; Male; Severity of Illness Index; Tetrazoles | 2016 |
Dynamic prediction model and risk assessment chart for cardiovascular disease based on on-treatment blood pressure and baseline risk factors.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Endpoint Determination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Models, Theoretical; Predictive Value of Tests; Proportional Hazards Models; Risk Assessment; Risk Factors; Sex Factors; Tetrazoles | 2016 |
Persistent olmesartan-based blood pressure-lowering effects on morning hypertension in Asians: the HONEST study.
Topics: Aged; Antihypertensive Agents; Asian People; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome | 2016 |
Sprue-like enteropathy linked to olmesartan.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Celiac Disease; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles | 2016 |
Patient Adherence to Olmesartan/Amlodipine Combinations: Fixed Versus Extemporaneous Combinations.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Tetrazoles | 2016 |
The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Oxadiazoles; Self Care; Telmisartan; Tetrazoles; Time Factors; Valsartan | 2016 |
Prognostic significance of on-treatment home and clinic blood pressure for predicting cardiovascular events in hypertensive patients in the HONEST study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Cardiovascular Diseases; Female; Humans; Hypertension; Imidazoles; Japan; Male; Middle Aged; Office Visits; Prognosis; Self Care; Tetrazoles | 2016 |
Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy.
Topics: Aged; Celiac Disease; Duodenum; Humans; Hypertension; Imidazoles; Liver; Male; Non-alcoholic Fatty Liver Disease; Tetrazoles | 2016 |
Home blood pressure and cardiovascular risk in treated hypertensive patients: the prognostic value of the first and second measurements and the difference between them in the HONEST study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Tetrazoles | 2016 |
Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension.
Topics: Absorption, Physiological; Adult; Age Factors; Aged; Antihypertensive Agents; Biological Variation, Population; Body Surface Area; Humans; Hypertension; Imidazoles; India; Metabolic Clearance Rate; Middle Aged; Models, Biological; Olmesartan Medoxomil; Prodrugs; Tetrazoles | 2017 |
Blood Pressure Reduction is Associated With the Changes in Oxidative Stress and Endothelial Activation in Hypertension, Regardless of Antihypertensive Therapy.
Topics: Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Endothelium, Vascular; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Oxidative Stress; Tetrazoles; Vitamins | 2016 |
Olmesartan with azelnidipine versus with trichlormethiazide on home blood pressure variability in patients with type II diabetes mellitus.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Diabetes Mellitus, Type 2; Dihydropyridines; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Pilot Projects; Tetrazoles; Trichlormethiazide | 2017 |
Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects.
Topics: Adult; Antigens, CD34; Antihypertensive Agents; Female; Humans; Hypertension; Imidazoles; Male; MicroRNAs; Middle Aged; Reactive Oxygen Species; Stem Cells; Tetrazoles | 2017 |
[Lowering blood pressure and more? AT1 antagonist reduced plaque volume].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Atenolol; Blood Pressure; Carotid Stenosis; Humans; Hypertension; Imidazoles; Randomized Controlled Trials as Topic; Tetrazoles | 2008 |
Quality of life in hypertension management using olmesartan in primary care.
Topics: Antihypertensive Agents; Blood Pressure; Female; Health Status; Heart Rate; Humans; Hypertension; Imidazoles; Male; Mental Health; Middle Aged; Primary Health Care; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tetrazoles | 2008 |
Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cathepsins; Cells, Cultured; Fibrosis; Heart Failure; Humans; Hypertension; Imidazoles; Leucine; Myocardium; Myocytes, Cardiac; NADPH Oxidases; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Sodium Chloride; Superoxides; Tetrazoles; Ventricular Remodeling | 2008 |
Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Capillaries; Enalapril; Glucose Transporter Type 4; Hypertension; Imidazoles; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Myocardium; Quadriceps Muscle; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Insulin; Renin-Angiotensin System; Signal Transduction; Tetrazoles; Transcription Factors | 2008 |
Enhanced pulsatile pressure accelerates vascular smooth muscle migration: implications for atherogenesis of hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Calcium Signaling; Cell Movement; Cells, Cultured; Dihydropyridines; Disease Models, Animal; Equipment and Supplies; Estrenes; Hypertension; Imidazoles; Inositol 1,4,5-Trisphosphate Receptors; Macrocyclic Compounds; Muscle, Smooth, Vascular; Oxazoles; Pyrrolidinones; Rats; Rats, Wistar; Signal Transduction; Tetrazoles; Type C Phospholipases | 2008 |
Effect of olmesartan on tissue expression balance between angiotensin II receptor and its inhibitory binding molecule.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Blotting, Western; Disease Models, Animal; Gene Expression; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Ventricular Remodeling | 2008 |
Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cell Degranulation; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Mast Cells; Protein Kinase C-delta; Protein Kinase C-epsilon; Protein Kinase Inhibitors; Rats; Rats, Inbred Dahl; Signal Transduction; Tetrazoles; Time Factors | 2008 |
Favorable cardiac and aortic remodeling in olmesartan-treated spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Hydralazine; Hypertension; Imidazoles; Male; Myocytes, Cardiac; Rats; Tetrazoles; Ventricular Remodeling | 2009 |
Renal and vascular glutathione S-transferase mu is not affected by pharmacological intervention to reduce systolic blood pressure.
Topics: Acetylcysteine; Animals; Glutathione Transferase; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Kidney; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Superoxides; Systole; Tetrazoles | 2009 |
Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats.
Topics: Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Electric Stimulation; Heart Atria; Heart Conduction System; Hypertension; Imidazoles; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 2009 |
Re: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination.
Topics: Amlodipine; Antihypertensive Agents; Clinical Trials as Topic; Dosage Forms; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Tablets; Tetrazoles; Treatment Failure; Treatment Outcome; Valine; Valsartan | 2009 |
Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Carotid Arteries; Hypertension; Imidazoles; Immunohistochemistry; In Vitro Techniques; Male; Muscle Relaxation; NADPH Oxidases; Peptidyl-Dipeptidase A; Protective Agents; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Renin; Reverse Transcriptase Polymerase Chain Reaction; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Tetrazoles; Valine; Valsartan; Vascular Diseases | 2009 |
AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Calcitonin Gene-Related Peptide; Capsaicin; Cells, Cultured; Ganglia, Spinal; Hypertension; Imidazoles; Insulin-Like Growth Factor I; Kidney; Losartan; Male; Myocardium; Nifedipine; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; RNA, Messenger; Sensory Receptor Cells; Telmisartan; Tetrazoles; Valine; Valsartan; Vasodilator Agents | 2009 |
Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Brain; Electron Spin Resonance Spectroscopy; Heart Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Imidazoles; Male; NADPH Oxidases; Norepinephrine; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Tetrazoles | 2009 |
Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension--results from the EUTOPIA trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Biomarkers; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Male; Middle Aged; Osteopontin; Pravastatin; Prospective Studies; Randomized Controlled Trials as Topic; Tetrazoles | 2010 |
Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-stroke patients.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cerebrovascular Circulation; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Stroke; Stroke Rehabilitation; Tetrazoles; Young Adult | 2009 |
Porphyria cutanea tarda induced by olmesartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Biopsy; Humans; Hypertension; Imidazoles; Male; Middle Aged; Porphyria Cutanea Tarda; Skin; Tetrazoles | 2010 |
Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Benzimidazoles; Biological Transport; Biphenyl Compounds; Digoxin; Fluoresceins; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Membrane Transport Proteins; Mice; Multidrug Resistance-Associated Protein 2; Olmesartan Medoxomil; Tetrazoles; Thiophenes | 2010 |
Olmesartan, an angiotensin II receptor blocker, restores cerebral hypoperfusion in elderly patients with hypertension.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Brain; Cerebrovascular Circulation; Cysteine; Female; Humans; Hypertension; Imidazoles; Magnetic Resonance Imaging; Male; Organotechnetium Compounds; Tetrazoles; Tomography, Emission-Computed, Single-Photon | 2010 |
Pharmacological therapy for hypertensive children: an "additional bypass" of lifestyle interventions.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Child; Humans; Hypertension; Imidazoles; Life Style; Obesity; Safety; Tetrazoles | 2010 |
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Desoxycorticosterone; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Glomerulonephritis; Heart Diseases; Hydralazine; Hypertension; Imidazoles; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Kidney Diseases; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nephrectomy; Sodium Chloride, Dietary; Species Specificity; Telemetry; Tetrazoles; Time Factors; X-Ray Microtomography | 2010 |
Olmesartan associated with acute renal failure in a patient with bilateral renal artery stenosis.
Topics: Acute Kidney Injury; Aged; Angiotensin II Type 1 Receptor Blockers; Heart Failure; Humans; Hypertension; Imidazoles; Male; Renal Artery Obstruction; Tetrazoles | 2010 |
Improving quality of life in hypertension management using a fixed-dose combination of olmesartan and amlodipine in primary care.
Topics: Aged; Amlodipine; Antihypertensive Agents; Diastole; Drug Combinations; Female; Heart Rate; Humans; Hypertension; Imidazoles; Male; Middle Aged; Primary Health Care; Quality of Life; Surveys and Questionnaires; Systole; Tetrazoles | 2010 |
Efficacy of olmesartan therapy on fibrinolytic capacity in patients with hypertension.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Female; Fibrinolysis; Humans; Hypertension; Imidazoles; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Tetrazoles; Thrombomodulin | 2011 |
Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood-Brain Barrier; Body Weight; Capillary Permeability; Cognition; Corpus Callosum; Hippocampus; Hypertension; Imidazoles; Immunohistochemistry; Male; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Inbred Dahl; RNA, Messenger; Systole; Tetrazoles | 2011 |
[Fixed drug combinations in hypertension: a budget impact analysis for the Spanish Health System on the marketing of a fixed combination of olmesartan/amlodipine].
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Costs and Cost Analysis; Decision Trees; Drug Combinations; Humans; Hypertension; Imidazoles; Middle Aged; National Health Programs; Spain; Tetrazoles | 2011 |
Effects of olmesartan on blood pressure and insulin resistance in hypertensive patients with sleep-disordered breathing.
Topics: Adult; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Mass Index; Female; Humans; Hypertension; Imidazoles; Insulin; Insulin Resistance; Japan; Male; Middle Aged; Pilot Projects; Prospective Studies; Sleep Apnea Syndromes; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography; Ventricular Function, Left | 2011 |
Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Risk Factors; Tetrazoles; Treatment Outcome | 2011 |
Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Progression; Glomerulosclerosis, Focal Segmental; Hypertension; Imidazoles; Kidney; Kidney Diseases; Male; NF-E2 Transcription Factor; NF-kappa B; Oxidative Stress; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Tetrazoles; Thiobarbituric Acid Reactive Substances | 2011 |
The 'pyrrhic victory' of amlodipine over hydrochlorothiazide in the OLAS Study.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Body Mass Index; Comorbidity; Drug Therapy, Combination; Endpoint Determination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Life Style; Metabolic Syndrome; Tetrazoles; Treatment Outcome | 2011 |
The effect of antihypertensive agents in people at high risk of cardiovascular disease and diabetes: a view through smoke and mirrors.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Metabolic Syndrome; Risk Factors; Tetrazoles; Treatment Outcome | 2011 |
A pooled analysis of 20 post-authorization surveys of olmesartan involving 156,682 hypertensive patients.
Topics: Aged; Humans; Hypertension; Imidazoles; Tetrazoles | 2011 |
Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats.
Topics: Acute Kidney Injury; Aldosterone; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Eplerenone; Hypertension; Imidazoles; Immunohistochemistry; Kidney; Male; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Sodium Chloride; Spironolactone; Tetrazoles | 2011 |
Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aorta; Calcium Channel Blockers; Confidence Intervals; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Renin-Angiotensin System; Research Design; Severity of Illness Index; Tetrazoles | 2011 |
Efficacy of amlodipine and olmesartan medoxomil in hypertensive patients with diabetes and obesity.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Prospective Studies; Tetrazoles | 2011 |
Choice of angiotensin receptor blocker in moderate hypertension. A UK-based cost-benefit comparison of olmesartan- and candesartan-based regimens.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Cohort Studies; Cost-Benefit Analysis; Decision Making; Humans; Hypertension; Imidazoles; Outcome Assessment, Health Care; Tetrazoles; United Kingdom | 2011 |
L-/T-type Ca channel blockers for kidney protection: ready for sophisticated use of Ca channel blockers.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Azetidinecarboxylic Acid; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Female; Humans; Hypertension; Imidazoles; Male; Tetrazoles | 2011 |
Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study.
Topics: Aged; Angiotensin II Type 2 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Urea Nitrogen; Cholesterol; Cholesterol, LDL; Cohort Studies; Creatinine; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Imidazoles; Kidney; Lipid Metabolism; Male; Middle Aged; Potassium; Retrospective Studies; Tetrazoles; Triglycerides | 2011 |
Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Hypertension; Imidazoles; Kidney; Male; Oxidative Stress; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Sexual Maturation; Sodium Chloride, Dietary; Tetrazoles | 2011 |
Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Benzopyrans; Blotting, Western; Enzyme Inhibitors; Ethanolamines; Hydrogen Peroxide; Hypertension; Imidazoles; Kidney Failure, Chronic; Male; Nebivolol; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Superoxide Dismutase; Tetrazoles | 2012 |
Severe angioedema associated with olmesartan.
Topics: Adrenal Cortex Hormones; Aged; Angioedema; Angiotensin II Type 1 Receptor Blockers; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Hypertension; Imidazoles; Severity of Illness Index; Tetrazoles; Treatment Outcome | 2011 |
Blood pressure outcomes in patients receiving angiotensin II receptor blockers in primary care: a comparative effectiveness analysis from electronic medical record data.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Black or African American; Blood Pressure; Diabetes Mellitus; Electronic Health Records; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Obesity; Primary Health Care; Retrospective Studies; Tetrazoles; Treatment Outcome; Valine; Valsartan; White People; Young Adult | 2011 |
Aldosterone does not contribute to renal p21 expression during the development of angiotensin II-induced hypertension in mice.
Topics: Actins; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cellular Senescence; Eplerenone; Genes, p16; Genes, p53; Hydralazine; Hypertension; Imidazoles; Kidney; Mice; Mice, Inbred C57BL; p21-Activated Kinases; Sirtuin 1; Sodium Chloride; Spironolactone; Tetrazoles | 2012 |
Effect of Olmesartan on serum cystatin C levels in the patients with essential hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Blood Pressure; Cystatin C; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles | 2011 |
Calcium antagonist added to angiotensin receptor blocker: a recipe for reducing blood pressure variability?: evidence from day-by-day home blood pressure monitoring.
Topics: Azetidinecarboxylic Acid; Blood Pressure; Dihydropyridines; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Tetrazoles | 2012 |
[Hypertension: improved therapy adherence after switch to a fixed drug combinations].
Topics: Amlodipine; Antihypertensive Agents; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Drug Substitution; Germany; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Medication Adherence; Olmesartan Medoxomil; Tetrazoles | 2012 |
Effects of olmesartan, an angiotensin II receptor blocker, on peripheral insulin sensitivity in Japanese subjects with type 2 diabetes and hypertension.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Asian People; Diabetes Mellitus, Type 2; Drug Resistance; Female; Glucose Clamp Technique; Humans; Hypertension; Imidazoles; Insulin Resistance; Japan; Male; Middle Aged; Receptor Cross-Talk; Tetrazoles | 2012 |
Hypertension in older adults: progress and limitations.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Imidazoles; Male; Tetrazoles | 2012 |
Increase in body Na+/water ratio is associated with cerebral aneurysm formation in oophorectomized rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Blotting, Western; Body Water; Carotid Arteries; Female; Humans; Hypertension; Imidazoles; Intracranial Aneurysm; Ligation; Ovariectomy; Rats; Rats, Sprague-Dawley; Renal Artery; Sodium; Sodium Chloride, Dietary; Sodium-Potassium-Exchanging ATPase; Tetrazoles; Up-Regulation; Water-Electrolyte Balance | 2012 |
Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Circadian Rhythm; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Incidence; Japan; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome; Young Adult | 2013 |
How important is it to control nocturnal hypertension with angiotensin II type 1 receptor blockers?
Topics: Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Circadian Rhythm; Female; Humans; Hypertension; Imidazoles; Male; Proteinuria; Renal Insufficiency, Chronic; Tetrazoles | 2013 |
[Modern hypertension treatment. More than effective blood pressure reduction].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Humans; Hypertension; Imidazoles; Randomized Controlled Trials as Topic; Tetrazoles | 2012 |
[The future of hypertension management lies in the use of fixed combinations (interview by Dr. Silke Wedekind)].
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Drug Combinations; Humans; Hypertension; Imidazoles; Receptor, Angiotensin, Type 1; Tetrazoles | 2012 |
Clinical and economic outcomes associated with amlodipine/renin-angiotensin system blocker combinations.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Insurance Claim Review; Linear Models; Male; Medication Adherence; Middle Aged; Renin-Angiotensin System; Retrospective Studies; Tetrazoles; Treatment Outcome | 2013 |
Difficult-to-control hypertension: effects of olmesartan-based combination therapies.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Imidazoles; Tetrazoles | 2013 |
Olmesartan-based therapies: an effective way to improve blood pressure control and cardiovascular protection.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Tetrazoles; Treatment Failure | 2013 |
Pharmacological and pharmacokinetic study of olmesartan medoxomil in animal diabetic retinopathy models.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Area Under Curve; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Glycated Hemoglobin; Heart Rate; Hypertension; Hypoxia; Imidazoles; Male; Olmesartan Medoxomil; Oxygen; Rats; Rats, Inbred SHR; Retinal Neovascularization; Tetrazoles | 2005 |
["High dosage monotherapy"].
Topics: Animals; Antihypertensive Agents; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypertension; Imidazoles; Patient Compliance; Proteinuria; Tetrazoles | 2005 |
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiomegaly; Collagen; Disease Progression; Endothelium, Vascular; Heart Rate; Hypertension; Imidazoles; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles; Vascular Diseases; Vascular Resistance | 2005 |
Chronic administration of olmesartan attenuates the exaggerated pressor response to glutamate in the rostral ventrolateral medulla of SHR.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Autonomic Pathways; Blood Pressure; Drug Administration Schedule; Drug Interactions; Excitatory Amino Acid Agonists; Glutamic Acid; Hypertension; Imidazoles; Male; Medulla Oblongata; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, N-Methyl-D-Aspartate; Reticular Formation; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles; Treatment Outcome; Vasoconstriction | 2005 |
Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
Topics: Adiponectin; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Glucose; Dose-Response Relationship, Drug; Glucose Tolerance Test; Hypertension; Imidazoles; Injections, Subcutaneous; Insulin; Insulin Resistance; Leptin; Male; Oligopeptides; Pyridines; Rats; Rats, Wistar; Receptors, Adiponectin; Receptors, Cell Surface; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |
Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Creatine; Hypertension; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Male; Nephrectomy; Organ Size; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium Chloride; Tetrazoles; Transforming Growth Factor beta | 2006 |
Effects of angiotensin II type 1 receptor blockade on the systemic blood nitric oxide dynamics in Nomega-nitro-L-arginine methyl ester-treated rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Electron Spin Resonance Spectroscopy; Endothelium, Vascular; Heart Rate; Hemodynamics; Hemoglobins; Hydralazine; Hypertension; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Tetrazoles | 2006 |
Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects.
Topics: Animals; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Pravastatin; Rats; Rats, Inbred Dahl; Reference Values; Risk Factors; Sensitivity and Specificity; Sodium Chloride, Dietary; Tetrazoles; Vascular Diseases | 2007 |
Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Chemokine CCL2; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Inflammation; Male; NADPH Oxidases; Oxidative Stress; Random Allocation; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Tetrazoles; Transforming Growth Factor beta1; Ventricular Remodeling | 2007 |
Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients.
Topics: Adult; Amlodipine; Blood Chemical Analysis; Cohort Studies; Coronary Circulation; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Middle Aged; Positron-Emission Tomography; Probability; Prospective Studies; Risk Assessment; Tetrazoles; Treatment Outcome; Vasodilation | 2007 |
Two amlodipine/ARB combinations for hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Blockers; Drug Combinations; Humans; Hypertension; Imidazoles; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2007 |
Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Inflammation; Japan; Male; Metabolic Syndrome; Middle Aged; Telmisartan; Tetrazoles | 2008 |
Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Drug Therapy, Combination; Enzyme Inhibitors; Heart Failure; Hypertension; Imidazoles; Male; Protein Kinase C-epsilon; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Tetrazoles | 2008 |
Effects of antihypertensive drugs and exercise training on insulin sensitivity in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure; Combined Modality Therapy; Dihydropyridines; Disease Models, Animal; Drug Therapy, Combination; Heart Rate; Hypertension; Imidazoles; Insulin; Insulin Resistance; Male; Muscle, Skeletal; Physical Conditioning, Animal; Rats; Rats, Inbred SHR; Regression Analysis; Sympathetic Nervous System; Tetrazoles | 2008 |
Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Aorta, Abdominal; Blood Pressure; Carotid Arteries; Catheterization; Disease Models, Animal; Heart Rate; Hyperplasia; Hypertension; Imidazoles; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Tunica Intima | 2008 |